Document:

Exhibit 10.34

REGISTRATION RIGHTS AGREEMENT

BETWEEN

EMISPHERE TECHNOLOGIES, INC.

AND

NOVARTIS PHARMA AG

Dated as of November 29, 2004

                       REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of November 29, 2004, between NOVARTIS PHARMA AG, a corporation organized under the laws of Switzerland (the “Initial Holder”) and EMISPHERE TECHNOLOGIES, INC., a Delaware corporation (the “Company”).

                       WHEREAS, contemporaneously herewith, the Company is issuing to the Initial Holder that certain Convertible Promissory Note Due November 29, 2009 (the “Note”);

                       WHEREAS, capitalized terms used and not otherwise defined herein shall have their respective meanings as defined in the Note,

                       WHEREAS, pursuant to, and subject to the terms and conditions of, the Note, the Company may require the Initial Holder to convert all or any portion of the principal amount of the Note, and any accrued Interest thereon, into Conversion Shares; and

                       WHEREAS, the Company and the Initial Holder desire to execute and deliver this Agreement in order to provide the Initial Holder with registration rights with respect to the Conversion Shares, as set forth in this Agreement.

                       NOW, THEREFORE, in consideration of the foregoing and of the mutual premises, covenants and conditions contained in this Agreement, the parties agree as follows:

          1.          Registration Under Securities Act, etc.

          1.1        Shelf Registration.  Prior to the occurrence of the first Conversion Date, the Company shall prepare and file with the Commission a registration statement covering the resale from time to time of all of the Registrable Securities on a delayed or continuous basis pursuant to Rule 415 (or any successor provision) under the Securities Act (the “Registration Statement”).  The Registration Statement shall be on Form S-3, if available, or, if Form S-3 is not available, on another appropriate form permitting registration of all Registrable Securities.  The Company shall use its best efforts to have the Registration Statement declared effective by the Commission as soon as practicable after such filing (and in any event prior to the Conversion Date, it being acknowledged and agreed that no conversion shall be permitted under
Section 3(a) of the Note unless and until the Registration Statement has been declared effective by the Commission) and, thereafter, to keep the Registration Statement continuously effective (including, if necessary, by filing with the Commission a post-effective amendment or a supplement to the Registration Statement or the related prospectus or any document incorporated therein by reference, or by filing any other required document or otherwise supplementing or amending the Registration Statement, if required by the rules, regulations or instructions applicable to the registration form under the Securities Act used by the Company for such Registration Statement or by the Securities Act, any state securities or “blue sky” laws or any other rules or regulations thereunder) until the earlier of (a) such time as all of the Registrable Securities shall have been sold and (b) the later of (i) the time when all Registrable Securities are eligible to be sold without volume or other restriction
pursuant to Rule 144 under the Securities Act and (ii) the [ninth (9th)] anniversary of the effectiveness of the Registration Statement.  No securities other than the Registrable Securities shall be included in the Shelf Registration Statement without the prior written consent of the Initial Holder.

          Subject to Section 8 of this Agreement, the Company shall supplement or amend, if necessary, the Shelf Registration, as required by the Securities Act or the rules and regulations under the Securities Act or as reasonably requested by the Initial Holder, and the Company shall furnish to the Initial Holder copies of any supplement or amendment prior to its being used and/or filed with the Commission.  The Company shall pay all Registration Expenses incurred in connection with the Shelf Registration and any supplements or amendments to it, whether or not it becomes effective, and whether all, none or some of the Registrable Securities are sold under the Shelf Registration.

          1.2        Registration Procedures.  In connection with the Registration Statement filed under Section 1.1, the Company shall, as expeditiously as possible:

                       (a)          subject to Section 8 of this Agreement, prepare and file with the Commission any amendments and supplements to the Registration Statement and the prospectus used in connection with it as may be necessary to keep the Registration Statement effective and to comply with the provisions of the Securities Act with respect to the disposition of the Registrable Securities covered by the Registration Statement or as may be reasonably requested by the Initial Holder, until all of the Registrable Securities have been disposed of in accordance with the intended methods of disposition set forth in the registration statement;

                       (b)          furnish to the Initial Holder and the underwriters, if any, the number of conformed copies of the registration statement and of each amendment and supplement to it (in each case including all exhibits) and the number of copies of the prospectus contained in the registration statement (including each preliminary prospectus and any summary prospectus) and any other prospectus filed under Rule 424 under the Securities Act and any other documents, as the Initial Holder may reasonably request, and the Company hereby consents to the use of such prospectuses and other documents by the Initial Holder in connection with the offering and sale of any Registrable Securities;

                       (c)          use its best efforts (x) to register or qualify all Registrable Securities covered by the registration statement under any other securities or blue sky laws where an exemption is not available and as the Initial Holder shall reasonably request, (y) to keep such registrations or qualifications in effect for so long as the Registration Statement remains in effect, and (z) to take any other action which may be reasonably necessary or advisable to enable the Initial Holder to consummate the disposition of all Registrable Securities, except that the Company shall not be required to qualify generally to do business as a foreign corporation in any jurisdiction where it would not, but for the requirements of this Section 1.2(c), be obligated to be so qualified, subject
itself to taxation in any jurisdiction in which it is not currently subject to taxation or consent to general service of process in any jurisdiction in which it has not hitherto consented to such service of process;

                       (d)          use its best efforts to cause all Registrable Securities covered by the Registration Statement to be registered with or approved by any other federal or state governmental agencies or authorities as may be necessary or desirable in the opinion of counsel to the Initial Holder to enable the Initial Holder lawfully to consummate the disposition of the Registrable Securities;

2

                       (e)          subject to Section 8 of this Agreement, promptly notify the Initial Holder and the underwriters, if any, at any time when a prospectus relating to the Registration Statement is required to be delivered under the Securities Act, upon discovery that, or upon the happening of any event as a result of which, the prospectus included in the Registration Statement, as then in effect, includes an untrue statement of a material fact or omits to state any material fact required to be stated in it or necessary to make the statements in it not misleading, in the light of the circumstances under which they were made and, at the request of the Initial Holder, promptly prepare and furnish to the Initial Holder and the underwriters, if any, a reasonable number of copies of a
supplement to or an amendment of the prospectus as may be necessary so that, as delivered to the purchasers of the securities, the prospectus shall not include an untrue statement of a material fact or omit to state a material fact required to be stated in it or necessary to make the statements in it not misleading in the light of the circumstances under which they were made;

                       (f)          otherwise use its best efforts to comply with all applicable rules and regulations of the Commission, and make available to the Initial Investor, as soon as reasonably practicable, an earnings statement covering the period of at least twelve months, but not more than eighteen months, beginning with the first full calendar month after the effective date of the Registration Statement, which earnings statement shall satisfy the provisions of Section 11(a) of the Securities Act and Rule 158 under the Securities Act, and promptly furnish to the Initial Holder and the underwriters, if any, a copy of any amendment or supplement to the Registration Statement or prospectus;

                       (g)          furnish to the Initial Holder a copy of all material documents filed with and all material correspondence from or to the Commission in connection with the Registration Statement or any Registrable Securities;

                       (h)          use its best efforts to list all Registrable Securities covered by the registration statement on the NYSE, the AMEX or another national securities exchange on which Registrable Securities of the same class and, if applicable, series, covered by the registration statement are then listed or on NASDAQ if the Registrable Securities are quoted on NASDAQ;

                       (i)          provide a transfer agent and registrar for all Registrable Securities and a CUSIP number for all such Registrable Securities, in each case not later than the effective date of registration;

                       (j)          in the event of an underwritten offering, enter into such agreements (including an underwriting agreement in form, scope and substance as is customary in underwritten offerings) and take all other appropriate and reasonable actions requested by the Initial Holder (including those reasonably requested by the managing underwriters) in order to expedite or facilitate the disposition of the Registrable Securities, and in that connection (x) use its best efforts to obtain opinions of counsel to the Company (which counsel and opinions (in form, scope and substance) shall be reasonably satisfactory to the managing underwriters and the Initial Holder), addressed to each of the underwriters as to the matters customarily covered in opinions requested in underwritten public
offerings of securities and such other matters as may be reasonably requested by the underwriters or the Initial Holder, (y) use its best efforts to obtain “cold comfort” letters from the independent certified public accountants of the Company (and, if necessary, any other independent certified public accountants of any subsidiary of the Company

3

or of any business acquired by the Company for which financial statements and financial data are, or are required to be, included in the Registration Statement), addressed to each of the underwriters, in customary form and covering matters of the type customarily covered in “cold comfort” letters in connection with underwritten public offerings of securities and (z) if requested and if an underwriting agreement is entered into, provide indemnification provisions and procedures substantially to the effect set forth in Section 1.4 with respect to all parties to be indemnified under Section 1.4.  The above shall be done at each closing under an underwriting or similar agreement, or as and to the extent required under it; and

                       (k)          notify the Initial Holder promptly and, if requested by the Initial Holder, confirm such advice in writing when any Registration Statement has become effective and when any post-effective amendments or supplements thereto become effective;

          The Company may (i) require the Initial Holder to furnish the Company information regarding the Initial Holder and the planned distribution of the Registrable Securities as the Company may from time to time reasonably request in writing and (ii) require the Initial Holder to agree to comply with the Securities Act and the Exchange Act in connection with the registration and distribution of the Registrable Securities.

          Notwithstanding the foregoing, if any registration or comparable statement refers to the Initial Holder by name or otherwise as the holder of any securities of the Company and in its sole and exclusive judgment the Initial Holder is or might be a controlling person of the Company, the Initial Holder shall have the right to require the insertion in the registration statement of language, in form and substance reasonably satisfactory to the Initial Holder and the Company, to the effect that the holding by the Initial Holder of the securities is not to be construed as a recommendation by the Initial Holder of the investment quality of the Company’s securities covered by it and that the holding does not imply that the Initial Holder will assist in meeting any future financial requirements of the Company.

          The Initial Holder agrees by acquisition of the Registrable Securities that, as soon as practicable after receipt of any notice from the Company of the happening of any event of the kind described in Section 1.2(e) hereof, the Initial Holder shall discontinue its disposition of Registrable Securities under the Registration Statement until its receipt of the copies of the supplemented or amended prospectus contemplated by Section 1.2 (e) hereof and, if so directed by the Company, shall promptly deliver to the Company (at the Company’s expense) all copies, other than permanent file copies, then in its possession of the prospectus relating to the Registrable Securities current at the time of receipt of such notice.

          1.3        Preparation; Reasonable Investigation.  In connection with the preparation and filing of each Registration Statement under this Agreement, the Company (i) shall give the Initial Holder and the underwriters, if any, and counsel and accountants designated by the Initial Holder the opportunity to participate in the preparation of the Registration Statement, the prospectus included in it or filed separately with the Commission, and each amendment of or supplement to it, (ii) shall give each of them reasonable access to its books and records and opportunities to discuss the business of the Company with its officers and the independent public accountants who have audited its financial statements as shall be necessary, in the opinion of the Initial Holder and its counsel or accountants, to exercise their due diligence responsibilities and
to

4

conduct a reasonable investigation within the meaning of the Securities Act and (iii) shall promptly notify the Initial Holder, its counsel and the underwriters, if any, of any stop order issued or threatened by the Commission and promptly take all reasonable actions required to prevent the entry of a stop order or to remove it if entered.

          1.4        Indemnification.

                       (a)          Indemnification by the Company.  The Company will, and hereby does, indemnify and hold harmless, in the case of any Registration Statement filed under Section 1.1, the Initial Holder and each other Person who participates as an underwriter in the offering or sale of the securities and each other Person, if any, who controls the Initial Holder or any underwriter within the meaning of the Securities Act, and their respective directors, officers, partners, shareholders, employees and affiliates against any losses, claims, damages or liabilities, joint or several, to which the Initial Holder or any underwriter or any director, officer, partner, shareholder, employee, affiliate or controlling person may become subject under the Securities Act or otherwise,
including, without limitation, the fees and expenses of legal counsel, insofar as the losses, claims, damages or liabilities (or actions or proceedings, whether commenced or threatened, in that respect) arise out of or are based upon any untrue statement or alleged untrue statement of any material fact contained in any Registration Statement under which the securities were registered under the Securities Act, any preliminary prospectus, final prospectus or summary prospectus contained in it, or any amendment or supplement to it, or any omission or alleged omission to state in it a material fact required to be stated in it or necessary to make the statements in it in light of the circumstances in which they were made not misleading, or any violation by the Company of the Securities Act or any rule or regulation under the Securities Act applicable to the Company, and the Company will reimburse the Initial Holder or any underwriter and each director, officer, partner, shareholder, employee, affiliate and
controlling Person for any legal or any other expenses reasonably incurred by them in connection with investigating or defending any loss, claim, liability, action or proceeding; provided, that the Company shall not be liable to the extent that any loss, claim, damage, liability (or action or proceeding in that respect) or expense arises out of or is based upon an untrue statement or alleged untrue statement or omission or alleged omission made in the Registration Statement, any preliminary prospectus, final prospectus, summary prospectus, amendment or supplement in reliance upon and in conformity with written information furnished to the Company through an instrument duly executed by or on behalf of the Initial Holder or any underwriter, as the case may be, specifically stating that it is furnished for use in the preparation of the registration statement, preliminary prospectus, final prospectus, summary prospectus, amendment or supplement.  This indemnity shall remain in full force and
effect regardless of any investigation made by or on behalf of the Initial Holder or any director, officer, employee, affiliate, partner or controlling person and shall survive the transfer of the Registrable Securities by the Initial Holder.

                       (b)          Indemnification by the Initial Holder.  As a condition to including any Registrable Securities in any Registration Statement, the Company shall have received an undertaking reasonably satisfactory to it from the Initial Holder to indemnify and hold harmless (in the same manner and to the same extent as set forth in Section 1.4(a)) the Company, and each director, officer, employee and shareholder of the Company and each other Person, if any, who participates as an underwriter in the offering or sale of the securities and each other Person who 

5

controls the Company or any underwriter within the meaning of the Securities Act, with respect to any untrue statement or alleged untrue statement of a material fact contained in or any omission or alleged omission to state in it a material fact in any Registration Statement, any preliminary prospectus, final prospectus or summary prospectus contained in it, or any amendment or supplement to it, if the untrue statement or alleged untrue statement or omission or alleged omission was made in reliance upon and in conformity with written information furnished to the Company through an instrument duly executed by or on behalf of the Initial Holder specifically stating that it is furnished for use in the preparation of the registration statement, preliminary prospectus, final prospectus, summary prospectus, amendment or supplement; provided, that the liability of the Initial Holder under this Section 1.4(b) shall be limited to the amount of proceeds received by
the Initial Holder in the offering giving rise to the liability for which indemnification is sought under this Section 1.4(b).  This indemnity shall remain in full force and effect, regardless of any investigation made by or on behalf of the Company or any director, officer, employee, shareholder or controlling person and shall survive the transfer of the Registrable Securities by the Initial Holder.

                       (c)          Notices of Claims, etc.  Promptly after receipt by an indemnified party of notice of the commencement of any action or proceeding involving a claim referred to in the preceding subdivisions of this Section 1.4, the indemnified party will, if a claim in that respect is to be made against an indemnifying party, give written notice to the latter of the commencement of the action; provided, that the failure of any indemnified party to give notice as provided in this Section 1.4(c) shall not relieve the indemnifying party of its obligations under the preceding subdivisions of this Section 1.4, except to the extent that the indemnifying party is actually prejudiced by the failure to give notice. In case any action is brought against an indemnified party,
the indemnifying party shall be entitled to participate in and to assume the defense of the action, jointly with any other indemnifying party similarly notified to the extent that it may wish, with counsel reasonably satisfactory to the indemnified party, and after notice from the indemnifying party to the indemnified party of its election to assume the defense of the action, the indemnifying party shall not be liable to the indemnified party for any legal or other expenses subsequently incurred by the latter in connection with the defense of the action other than reasonable costs of investigation; provided, that if the indemnified party reasonably believes it is advisable for it to be represented by separate counsel because there exists a conflict of interest between its interests and those of the indemnifying party with respect to the claim, or there exist defenses available to the indemnified party which may not be available to the indemnifying party, or if the indemnifying party shall fail
to assume responsibility for the defense, the indemnified party may retain counsel satisfactory to it and the indemnifying party shall pay all fees and expenses of that counsel. No indemnifying party shall be liable for any settlement of any action or proceeding effected without its written consent, which consent shall not be unreasonably withheld or delayed.  No indemnifying party shall, without the consent of the indemnified party, consent to entry of any judgment or enter into any settlement which does not include as an unconditional term the giving by the claimant or plaintiff to the indemnified party of a release from all liability in respect of the claim or litigation or which requires action other than the payment of money by the indemnifying party.  Each indemnified party shall furnish information regarding itself or the claim in question as an indemnifying party may reasonably request in writing and as shall be reasonably requested in connection with the defense of the claim and
litigation resulting from it.

6

                       (d)          Contribution.  If the indemnification provided for in this Section 1.4 shall for any reason be held by a court of competent jurisdiction to be unavailable to an indemnified party under subparagraph (a) or (b) of this Section 1.4 in respect of any loss, claim, damage or liability, or any action in that respect, then, in lieu of the amount paid or payable under subparagraph (a) or (b) of this Section 1.4, the indemnified party and the indemnifying party under subparagraph (a) or (b) of this Section 1.4 shall contribute to the aggregate losses, claims, damages and liabilities (including legal or other expenses reasonably incurred in connection with investigating the same), (i) in the proportion as is appropriate to reflect the relative fault of the Company
and the Initial Holder in connection with the statements or omissions which resulted in the loss, claim, damage or liability, or action in that respect, as well as any other relevant equitable considerations (the relative fault of the Company and the Initial Holder to be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the Company or the Initial Holder, and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent the statement or omission) or (ii) if the allocation provided by clause (i) is not permitted by applicable law, in the proportion as shall be appropriate to reflect the relative benefits received by the Company and the Initial Holder from the offering of the securities covered by the registration statement.  The Company and the Initial Holder agree that it would not be just and
equitable if contribution pursuant to this Section 1.4(d) were based solely on the number of Persons from whom contribution was requested or by any other method of allocation which does not take account of the equitable considerations referred to in this Section 1.4(d).  No Person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any Person who was not guilty of fraudulent misrepresentation.  In addition, no Person shall be obligated to contribute any amounts in payment for any settlement of any action or claim effected without the Person’s consent, which consent shall not be unreasonably withheld or delayed.

                       (e)          Other Indemnification.  Indemnification and contribution similar to that specified in the preceding subsections of this Section 1.4 (with appropriate modifications) shall be given by the Company and the Initial Holder with respect to any required registration or other qualification of securities under any federal or state law, rule or regulation of any governmental authority other than the Securities Act.

                       (f)          Indemnification Payments.  The indemnification and contribution required by this Section 1.4 shall be made by prompt periodic payments during the course of the investigation or defense, as and when bills are received or expense, loss, damage or liability is incurred.

          2.          Definitions.  As used in this Agreement, unless the context otherwise requires, the following terms have the following meanings:

                       “Affiliate” means, with respect to any Person, any other Person that directly, or indirectly through one or more intermediaries, controls, is controlled by or is under common control with the subject Person.  For purposes of this definition, “control” (including, with correlative meaning, the terms “controlled by” and “under common control with”), as used with respect to any Person, shall mean the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of the Person, whether through the ownership of voting securities or by contract or otherwise.

7

                       “Agreement” has the meaning set forth in the preamble hereto.

                       “AMEX” means the American Stock Exchange, Inc.

                       “Commission” means the Securities and Exchange Commission or any other federal agency at the time administering the Securities Act.

                       “Company” has the meaning set forth in the preamble hereto.

                       “Exchange Act” means the Securities Exchange Act of 1934, as amended, or any successor federal statute, and the rules and regulations of the Commission under it, all as the same shall be in effect at the time.  Reference to a particular section of the Exchange Act, shall include a reference to the comparable section, if any, of any successor federal statute.

                       “Initial Holder” has the meaning set forth in the preamble hereto.

                       “NASD” means the National Association of Securities Dealers, Inc.

                       “NASDAQ” means the Nasdaq National Stock Market, Inc.

                       “Note” has the meaning set forth in the recitals to this Agreement.

                       “NYSE” means The New York Stock Exchange, Inc.

                       “Person” means any individual, corporation, partnership, trust, incorporated or unincorporated association, joint venture, joint stock company, government (or an agency, department or political subdivision of it) or other entity of any kind.

                       “Registrable Securities “ means (i) any Conversion Shares and (ii) any Related Registrable Securities.  As to any particular Registrable Securities, such securities shall cease to be Registrable Securities when (a) a Registration Statement with respect to the sale of such securities shall have become effective under the Securities Act and such securities shall have been disposed of in accordance with the Registration Statement, (b) such securities and all other Registrable Securities owned by the Initial Holder may be distributed to the public without volume or other restrictions pursuant to Rule 144 (or any successor provision) under the Securities Act, (c) such securities shall have been otherwise transferred, and new certificates for them not bearing a legend restricting further transfer shall have been
delivered by the Company and subsequent public distribution of them shall not, in the opinion of counsel to the Initial Holder, require registration under the Securities Act, or (d) they shall have ceased to be outstanding.

                       “Registration Expenses” means all costs, fees and expenses incident to the Company’s performance of or compliance with Section 1, including all registration, filing and NASD fees, all fees and expenses of complying with securities or blue sky laws, all word processing, duplicating and printing expenses, messenger and delivery expenses and the fees and disbursements of counsel for the Company and of its independent public accountants, but excluding any underwriting fees, expenses, discounts or other costs payable to any underwriter, broker or dealer.

8

                       “Registration Statement” has the meaning set forth in Section 1.1 of this Agreement.

                       “Related Registrable Securities” means any securities of the Company issued or issuable with respect to any Conversion Shares by way of a dividend or stock split or in connection with a combination of shares, recapitalization, merger, consolidation or other reorganization or otherwise.

                       “Securities Act” means the Securities Act of 1933, or any successor federal statute, and the rules and regulations of the Commission thereunder, all as the same shall be in effect at the time.  References to a particular section of the Securities Act shall include a reference to the comparable section, if any, of any successor federal statute.

          3.          Rule 144 and Rule 144A.  The Company shall take all actions reasonably necessary to enable the Initial Holder to sell all Registrable Securities without registration under the Securities Act within the limitation of the exemptions provided by (a) Rule 144 under the Securities Act, as such rule may be amended from time to time, (b) Rule 144A under the Securities Act, as such rule may be amended from time to time, or (c) any similar rules or regulations adopted by the Commission, including by filing on a timely basis all reports required to be filed by the Exchange Act and making available and keeping public information as those terms are defined in Rule 144 under the Securities Act.  Promptly upon any request of the Initial Holder from time to time, the Company shall deliver to the Initial Holder a written statement as to
whether it has complied with these requirements.

          4.          Amendments and Waivers.  This Agreement may not be amended, supplemented, or otherwise modified except by a writing signed by each party to this Agreement, and the Company shall not take any action prohibited by this Agreement, or omit to perform any act required to be performed by it, unless the Company shall have obtained the prior written consent of the Initial Holder to any such action or omission.

          5.          Nominees for Beneficial Owners.  In the event that any Registrable Securities are held by a nominee for the beneficial owner of the Registrable Securities, the beneficial owner may, at its election in writing delivered to the Company, be treated as the holder of the Registrable Securities for purposes of any request, consent, waiver or other action by any holder or holders of Registrable Securities under this Agreement or any determination of any number or percentage of shares of Registrable Securities held by any holder or holders of Registrable Securities contemplated by this Agreement.  If the beneficial owner of any Registrable Securities so elects, the Company may require assurances reasonably satisfactory to it of the owner’s beneficial ownership of the Registrable Securities.

9

          6.          Notices.  Any notices or other communications required or permitted under this Agreement shall be sufficiently given if delivered personally, sent by nationally recognized overnight delivery service or facsimile (receipt confirmed) or mailed by first-class mail, postage prepaid, addressed as follows:

	
   
  	
  
If to the   Company:
  
	
  
 
  	
  
 
  
	
  
 
  	
  
EMISPHERE   TECHNOLOGIES, INC
  
	
  
 
  	
  
765 Old Saw   Mill River Road 
  
	
  
 
  	
  
Tarrytown,   New York 10591
  
	
  
 
  	
  
Attention:  Elliot Maza
  
	
  
 
  	
  
Telephone:  (914) 785-4703
  
	
  
 
  	
  
Fax:  (914) 347-2498
  
	
  
 
  	
  
 
  
	
  
 
  	
  
with a   required copy (which shall not constitute notice) to:
  
	
  
 
  	
  
 
  
	
   
  	
  
Proskauer   Rose LLP
  
	
  
 
  	
  
1585   Broadway
  
	
  
 
  	
  
New York,   New York 10011
  
	
  
 
  	
  
Attention:   Robert Cantone, Esq.
  
	
  
 
  	
  
Telephone:  (212) 969-3000
  
	
  
 
  	
  
Fax:   (212) 969-2900
  
	
  
 
  	
  
 
  
	
  
 
  	
  
if to the   Initial Holder to:
  
	
  
 
  	
  
 
  
	
  
 
  	
  
NOVARTIS   PHARMA AG
  
	
  
 
  	
  
Lichtstrasse   35
  
	
   
  	
  
CH-4002
  
	
  
 
  	
  
Basel,   Switzerland
  
	
  
 
  	
  
Attention:  General Counsel
  
	
  
 
  	
  
Telephone:  41 61 324 6877
  
	
  
 
  	
  
Facsimile:  41 61 324 6859
  
	
  
 
  	
  
 
  
	
  
 
  	
  
with a   required copy (which shall not constitute notice) to:
  
	
  
 
  	
  
 
  
	
  
 
  	
  
White &   Case LLP
  
	
  
 
  	
  
1155 Avenue   of the Americas
  
	
  
 
  	
  
New York,   New York  10036
  
	
   
  	
  
Attention:  Oliver C. Brahmst, Esq.
  
	
  
 
  	
  
Telephone:  (212) 819-8200
  
	
  
 
  	
  
Fax:  (212) 354-8113
  

          All notices shall be deemed to have been received (x) on the date delivered, if delivered by facsimile or personally or (y) on the day after the notice is delivered into the possession and control of a nationally recognized overnight delivery service, duly marked for delivery to the receiving party.  A party may change the address to which notice or other communication under this Agreement is to be delivered by giving the other party notice in the manner set forth in this Section 6.  If any notice, filing, delivery or payment shall be required by the terms of this Agreement to be made on a day that is not a Business Day, the notice, filing, delivery or payment shall be made on the immediately succeeding Business Day.

10

          7.          Assignment.  This Agreement shall be binding upon and inure to the benefit of and shall be enforceable by the parties to this Agreement and their respective successors and assigns.

          8.          Holdback Agreements.  Notwithstanding anything in this Agreement to the contrary if (i) the Company shall determine in good faith that it would be materially adverse to the Company and its stockholders for any Registration Statement to be amended or supplemented and (ii) the need for an amendment or supplement is not caused by a proposed public offering of any securities of the Company by any of its security holders (other than an offering made under a registration on Form S-8), the Company may defer amending or supplementing the Registration Statement for not more than 90 days and, upon appropriate notice to the Initial Holder, the Initial Holder shall be required to discontinue disposition of any Registrable Securities covered by the Shelf Registration during such period.

          9.          No Inconsistent Agreements.  The Company will not enter into any agreement with respect to its securities which conflicts with the rights granted to the Initial Holder in this Agreement.

          10.        Severability.  Each provision of this Agreement shall be considered separable and if for any reason any provision which is not essential to the effectuation of the basic purpose of this Agreement shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired.

          11.        Entire Agreement.  This Agreement, together with the Note, constitute the entire agreement between the Company and the Initial Investor with respect to the transactions contemplated by those documents.

          12.        Section and Other Headings.  The section and other headings contained in this Agreement are for reference purposes only and shall not be deemed to be a part of this Agreement or to affect the meaning or interpretation of this Agreement.

          13.        Governing Law.  THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK, AS APPLIED TO CONTRACTS MADE AND PERFORMED WITHIN THE STATE OF NEW YORK, WITHOUT GIVING EFFECT TO THE PRINCIPLES OF CONFLICTS OF LAW TO THE EXTENT THAT THE APPLICATION OF LAWS OF ANOTHER JURISDICTION WOULD BE REQUIRED BY THEM.

          14.        Jurisdiction; Consent to Service of Process.  (a) Each of the parties hereto hereby irrevocably and unconditionally submits, for itself and its property, to the exclusive jurisdiction of any Federal court of the United States of America sitting in the State of New York, and any appellate court from any such court, in any action or proceeding arising out of or relating to this Agreement or the transactions contemplated hereby, or for recognition or enforcement of any judgment, and each of the parties hereto hereby irrevocably and unconditionally agrees that all claims in respect of any such action or proceeding shall be heard and determined in such Federal courts.  Each of the parties hereto agrees that a final judgment in any such action or proceeding shall be conclusive and may be enforced in any other jurisdiction by suit on the
judgment or in any other manner provided by law.

11

          (b) Each of the parties hereto hereby irrevocably and unconditionally waives, to the fullest extent it may legally and effectively do so, any objection which it may now or hereafter have to the laying of venue of any suit, action or proceeding arising out of or relating to this Agreement or the transactions contemplated hereby in any Federal court situated in the State of New York.  Each of the parties hereto hereby irrevocably waives, to the fullest extent permitted by law, the defense of an inconvenient forum to the maintenance of such action or proceeding in any such court.

          (c) Each of the parties hereto hereby irrevocably consents to service of process in the manner provided for notices in Section 6 hereof.  Nothing in this Agreement shall affect the right of any party hereto to serve process in any other manner permitted by law.

          15.        Waiver of Jury Trial.  Each of the parties hereto (i) consents to submit itself to the personal jurisdiction of any Federal court situated in the State of New York in the event any dispute arises out of this Agreement or any transaction contemplated hereby, (ii) agrees that it will not attempt to deny or defeat such personal jurisdiction by motion or other request for leave from any such court, (iii) agrees that it will not bring any action relating to this Agreement or any transaction contemplated hereby in any court other than a Federal court sitting in the State of New York and (iv) waives any right to trial by jury with respect to any claim or proceeding related to or arising out of this Agreement or any transaction contemplated hereby.

          16.        Specific Performance.  The parties hereto hereby acknowledge and agree that it would be impossible to measure in money the damages that would accrue to a party hereto by reason of any failure of the other party to perform any of its obligations under this Agreement.   Therefore, each party hereto shall be entitled to specific performance of the obligations of the other party under this Agreement.

          17.        Counterparts.  This Agreement may be executed in any number of counterparts, each of which shall be deemed an original, but all counterparts shall together constitute one and the same instrument.

12

          IN WITNESS WHEREOF, the parties have caused this Agreement to be executed and delivered by their respective officers each of whom is duly authorized as of the date first above written.

	
  
 
  	
  
EMISPHERE TECHNOLOGIES, INC
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
By:
  	
        /s/ Lewis
        H. Bender

    
	
   
  	
  
 
  	
  

  
	
  
 
  	
  
Name:
  	
        Lewis H.
        Bender

    
	
  
 
  	
  
Title:
  	
         Sr.
        Vice President, Business Development

    
	
  
 
  	
  
 
  
	
  
 
  	
  
NOVARTIS PHARMA   AG
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
By:
  	
        /s/ Joseph
        Mamie 

    
	
   
  	
   
  	
  

  
	
   
  	
  Name:
  	
       Joseph Mamie
        

    
	
   
  	
  Title:
  	
       Head Operations,
        TreasuryExecution Copy

Exhibit 10.35

COMMON STOCK PURCHASE AGREEMENT

by and between

KINGSBRIDGE CAPITAL LIMITED

and

EMISPHERE TECHNOLOGIES, INC.

dated as of December 27, 2004

TABLE OF CONTENTS

	
   
 	
   
 	
   
 	
   
 	
  
Page
  
	
   
 	
   
 	
   
 	
   
 	
  

  
	
  
ARTICLE I
  	
  
DEFINITIONS
  	
  
2
  
	
   
  	
  
Section   1.01.
  	
  
“Articles”
  	
  
2
  
	
  
 
  	
  
Section   1.02.
  	
  
“Blackout   Amount”
  	
  
2
  
	
  
 
  	
  
Section   1.03.
  	
  
“Blackout   Shares”
  	
  
2
  
	
  
 
  	
  
Section   1.04.
  	
  
“Closing   Date”
  	
  
2
  
	
  
 
  	
  
Section   1.05.
  	
  
“Commission”
  	
  
2
  
	
  
 
  	
  
Section   1.06.
  	
  
“Commission   Documents”
  	
  
2
  
	
   
  	
  
Section   1.07.
  	
  
“Commitment   Period”
  	
  
2
  
	
  
 
  	
  
Section   1.08.
  	
  
“Common   Stock”
  	
  
2
  
	
  
 
  	
  
Section   1.09.
  	
  
“Condition   Satisfaction Date”
  	
  
2
  
	
  
 
  	
  
Section   1.10.
  	
  
“Damages”
  	
  
2
  
	
  
 
  	
  
Section   1.11.
  	
  
“Draw Down”
  	
  
2
  
	
  
 
  	
  
Section   1.12.
  	
  
“Draw Down   Amount”
  	
  
2
  
	
   
  	
  
Section   1.13.
  	
  
“Draw Down   Discount Price”
  	
  
2
  
	
  
 
  	
  
Section   1.14.
  	
  
“Draw Down   Notice”
  	
  
3
  
	
  
 
  	
  
Section   1.15.
  	
  
“Draw Down   Pricing Period”
  	
  
3
  
	
  
 
  	
  
Section   1.16.
  	
  
“Effective   Date”
  	
  
3
  
	
  
 
  	
  
Section   1.17.
  	
  
“Exchange   Act”
  	
  
3
  
	
   
  	
  
Section   1.18.
  	
  
“Knowledge”
  	
  
3
  
	
  
 
  	
  
Section   1.19.
  	
  
“Make Whole   Amount”
  	
  
3
  
	
  
 
  	
  
Section   1.20.
  	
  
“Market   Capitalization”
  	
  
3
  
	
  
 
  	
  
Section   1.21.
  	
  
“Material   Adverse Effect”
  	
  
3
  
	
  
 
  	
  
Section   1.22.
  	
  
“Maximum   Commitment Amount”
  	
  
3
  
	
   
  	
  
Section   1.23.
  	
  
“Maximum   Draw Down Amount”
  	
  
3
  
	
  
 
  	
  
Section   1.24.
  	
  
“NASD”
  	
  
3
  
	
  
 
  	
  
Section   1.25.
  	
  
“Permitted   Transaction”
  	
  
3
  
	
  
 
  	
  
Section   1.26.
  	
  
“Person”
  	
  
3
  
	
  
 
  	
  
Section   1.27.
  	
  
“Principal   Market”
  	
  
4
  
	
  
 
  	
  
Section   1.28.
  	
  
“Prohibited   Transaction”
  	
  
4
  
	
   
  	
  
Section   1.29.
  	
  
“Prospectus”
  	
  
4
  
	
  
 
  	
  
Section   1.30.
  	
  
“Registrable   Securities”
  	
  
4
  
	
  
 
  	
  
Section   1.31.
  	
  
“Registration   Rights Agreement”
  	
  
4
  
	
  
 
  	
  
Section   1.32.
  	
  
“Registration   Statement”
  	
  
4
  

i

TABLE OF CONTENTS
 (Continued)

	
   
 	
   
 	
   
 	
   
 	
  Page
  
	
   
 	
   
 	
   
 	
   
 	
  

  
	
  
 
  	
  
Section   1.33.
  	
  
“Regulation   D”
  	
  
4
  
	
  
 
  	
  
Section   1.34.
  	
  
“Section4(2)”
  	
  
4
  
	
  
 
  	
  
Section   1.35.
  	
  
“Securities   Act”
  	
  
4
  
	
  
 
  	
  
Section   1.37.
  	
  
“Shares”
  	
  
4
  
	
   
  	
  
Section   1.38.
  	
  
“Threshold   Price”
  	
  
4
  
	
  
 
  	
  
Section   1.39.
  	
  
“Trading   Day”
  	
  
5
  
	
  
 
  	
  
Section   1.40.
  	
  
“VWAP”
  	
  
5
  
	
  
 
  	
  
Section   1.41.
  	
  
“Warrant”
  	
  
5
  
	
  
 
  	
  
Section   1.42.
  	
  
“Warrant Shares”
  	
  
5
  
	
  
ARTICLE II
  	
  
PURCHASE AND   SALE OF COMMON STOCK
  	
  
5
  
	
   
  	
  
Section   2.01.
  	
  
Purchase and   Sale of Stock
  	
  
5
  
	
  
 
  	
  
Section   2.02.
  	
  
Closing
  	
  
5
  
	
  
 
  	
  
Section   2.03.
  	
  
Registration   Statement and Prospectus
  	
  
5
  
	
  
 
  	
  
Section   2.04.
  	
  
Warrant
  	
  
5
  
	
  
 
  	
  
Section   2.05.
  	
  
Blackout   Shares
  	
  
5
  
	
  
ARTICLE III
  	
  
DRAW DOWN   TERMS
  	
  
6
  
	
   
  	
  
Section   3.01.
  	
  
Draw Down   Notice
  	
  
6
  
	
  
 
  	
  
Section   3.02.
  	
  
Number of   Shares
  	
  
6
  
	
  
 
  	
  
Section   3.03.
  	
  
Limitation   on Draw Downs
  	
  
6
  
	
  
 
  	
  
Section   3.04.
  	
  
Trading   Cushion
  	
  
6
  
	
  
 
  	
  
Section   3.05.
  	
  
Expiration   of Draw Downs
  	
  
6
  
	
  
 
  	
  
Section   3.06.
  	
  
Settlement
  	
  
6
  
	
   
  	
  
Section   3.07.
  	
  
Delivery of   Shares; Payment of Draw Down Amount
  	
  
6
  
	
  
 
  	
  
Section   3.08.
  	
  
Threshold   Price
  	
  
7
  
	
  
 
  	
  
Section   3.09.
  	
  
Other   Issuances
  	
  
7
  
	
  
 
  	
  
Section   3.10.
  	
  
Failure to   Deliver Shares
  	
  
7
  
	
  
ARTICLE IV
  	
  
REPRESENTATIONS   AND WARRANTIES OF THE COMPANY
  	
  
8
  
	
  
 
  	
  
Section   4.01.
  	
  
Organization,   Good Standing and Power
  	
  
8
  
	
   
  	
  
Section   4.02.
  	
  
Authorization;   Enforcement
  	
  
8
  
	
  
 
  	
  
Section   4.03.
  	
  
Capitalization
  	
  
8
  
	
  
 
  	
  
Section   4.04.
  	
  
Issuance of   Shares
  	
  
9
  
	
  
 
  	
  
Section   4.05.
  	
  
No Conflicts
  	
  
9
  
	
  
 
  	
  
Section   4.06.
  	
  
Commission   Documents, Financial Statements
  	
  
10
  

ii

TABLE OF CONTENTS
 (Continued)

	
   
 	
   
 	
   
 	
   
 	
  
Page
  
	
   
 	
   
 	
   
 	
   
 	
  

  
	
  
 
  	
  
Section   4.07.
  	
  
No Material   Adverse Change
  	
  
10
  
	
  
 
  	
  
Section   4.08.
  	
  
No   Undisclosed Liabilities
  	
  
10
  
	
   
  	
  
Section   4.09.
  	
  
No   Undisclosed Events or Circumstances
  	
  
10
  
	
  
 
  	
  
Section   4.10.
  	
  
Actions   Pending
  	
  
11
  
	
  
 
  	
  
Section   4.11.
  	
  
Compliance with   Law
  	
  
11
  
	
  
 
  	
  
Section   4.12.
  	
  
Certain Fees
  	
  
11
  
	
  
 
  	
  
Section   4.13.
  	
  
Disclosure
  	
  
11
  
	
  
 
  	
  
Section   4.14.
  	
  
Material   Non-Public Information
  	
  
11
  
	
   
  	
  
Section   4.15.
  	
  
Exemption   from Registration; Valid Issuances
  	
  
11
  
	
  
 
  	
  
Section   4.16.
  	
  
No General   Solicitation or Advertising in Regard to this Transaction
  	
  
12
  
	
  
 
  	
  
Section   4.17.
  	
  
No   Integrated Offering
  	
  
12
  
	
  
 
  	
  
Section   4.18.
  	
  
Acknowledgment   Regarding Investor’s Purchase of Shares
  	
  
12
  
	
  
ARTICLE V
  	
  
REPRESENTATIONS,   WARRANTIES AND COVENANTS OF THE INVESTOR
  	
  
12
  
	
   
  	
  
Section   5.01.
  	
  
Organization   and Standing of the Investor
  	
  
12
  
	
  
 
  	
  
Section   5.02.
  	
  
Authorization   and Power
  	
  
12
  
	
  
 
  	
  
Section   5.03.
  	
  
No Conflicts
  	
  
13
  
	
  
 
  	
  
Section   5.04.
  	
  
Financial   Capability
  	
  
13
  
	
  
 
  	
  
Section   5.05.
  	
  
Information
  	
  
13
  
	
  
 
  	
  
Section   5.06.
  	
  
Selling   Restrictions
  	
  
13
  
	
   
  	
  
Section   5.07.
  	
  
Statutory   Underwriter Status
  	
  
14
  
	
  
 
  	
  
Section   5.08.
  	
  
Not an   Affiliate
  	
  
14
  
	
  
 
  	
  
Section   5.09.
  	
  
Manner of   Sale
  	
  
14
  
	
  
ARTICLE VI
  	
  
COVENANTS OF   THE COMPANY
  	
  
14
  
	
  
 
  	
  
Section   6.01.
  	
  
Securities
  	
  
14
  
	
  
 
  	
  
Section   6.02.
  	
  
Reservation   of Common Stock
  	
  
14
  
	
   
  	
  
Section   6.03.
  	
  
Registration   and Listing
  	
  
15
  
	
  
 
  	
  
Section   6.04.
  	
  
Registration   Statement
  	
  
15
  
	
  
 
  	
  
Section   6.05.
  	
  
Compliance   with Laws
  	
  
15
  
	
  
 
  	
  
Section   6.06.
  	
  
Reporting   Requirements
  	
  
15
  
	
  
 
  	
  
Section   6.07.
  	
  
Other   Financing
  	
  
15
  
	
  
 
  	
  
Section   6.08.
  	
  
Prohibited   Transactions
  	
  
16
  
	
   
  	
  
Section   6.09.
  	
  
Corporate   Existence
  	
  
16
  

iii

TABLE OF CONTENTS
 (Continued)

	
   
 	
   
 	
   
 	
   
 	
  
Page
  
	
   
 	
   
 	
   
 	
   
 	
  

  
	
  
 
  	
  
Section   6.10.
  	
  
Non-Disclosure   of Non-Public Information
  	
  
16
  
	
   
  	
  
Section   6.11.
  	
  
Notice of   Certain Events Affecting Registration; Suspension of Right to Request a Draw   Down
  	
  
16
  
	
  
 
  	
  
Section   6.12.
  	
  
Amendments   to the Registration Statement
  	
  
17
  
	
  
 
  	
  
Section   6.13.
  	
  
Prospectus   Delivery
  	
  
17
  
	
  
 
  	
  
Section   6.14.
  	
  
Expectations   Regarding Draw Downs
  	
  
17
  
	
  
ARTICLE VII
  	
  
CONDITIONS   TO THE OBLIGATION OF THE INVESTOR TO ACCEPT A DRAW DOWN
  	
  
17
  
	
   
  	
  
Section   7.01.
  	
  
Accuracy of   the Company’s Representations and Warranties
  	
  
18
  
	
  
 
  	
  
Section   7.02.
  	
  
Performance   by the Company
  	
  
18
  
	
  
 
  	
  
Section   7.03.
  	
  
Compliance   with Law
  	
  
18
  
	
  
 
  	
  
Section   7.04.
  	
  
Effective   Registration Statement
  	
  
18
  
	
  
 
  	
  
Section   7.05.
  	
  
No Knowledge
  	
  
18
  
	
   
  	
  
Section   7.06.
  	
  
No   Suspension
  	
  
18
  
	
  
 
  	
  
Section   7.07.
  	
  
No   Injunction
  	
  
18
  
	
  
 
  	
  
Section   7.08.
  	
  
No Proceedings   or Litigation
  	
  
18
  
	
  
 
  	
  
Section   7.09.
  	
  
Section16   Limitation
  	
  
18
  
	
  
 
  	
  
Section   7.10.
  	
  
Sufficient   Shares Registered for Resale
  	
  
19
  
	
  
 
  	
  
Section   7.11.
  	
  
Warrant
  	
  
19
  
	
   
  	
  
Section   7.12.
  	
  
Opinion of   Counsel
  	
  
19
  
	
  
 
  	
  
Section   7.13.
  	
  
Accuracy of   Investor’s Representation and Warranties
  	
  
19
  
	
  
ARTICLE VIII
  	
  
TERMINATION
  	
  
19
  
	
  
 
  	
  
Section   8.01.
  	
  
Term
  	
  
19
  
	
  
 
  	
  
Section   8.02.
  	
  
Other   Termination
  	
  
19
  
	
  
 
  	
  
Section   8.03.
  	
  
Effect of   Termination
  	
  
20
  
	
   
  	
  
Section   9.01.
  	
  
Indemnification
  	
  
20
  
	
  
 
  	
  
Section 9.02.
  	
  
Notification of Claims for Indemnification
  	
  
21
  
	
  
 
  	
  
Section 9.03.
  	
  
Dispute Resolution
  	
  
23
  
	
  
ARTICLE X
  	
  
MISCELLANEOUS
  	
  
23
  
	
  
 
  	
  
Section   10.01.
  	
  
Fees and   Expenses
  	
  
23
  
	
  
 
  	
  
Section   10.02.
  	
  
Reporting   Entity for the Common Stock
  	
  
24
  
	
   
  	
  
Section   10.03.
  	
  
Brokerage
  	
  
24
  
	
  
 
  	
  
Section   10.04.
  	
  
Notices
  	
  
24
  

iv

TABLE OF CONTENTS
 (Continued)

	
   
 	
   
 	
   
 	
   
 	
  
Page
  
	
   
 	
   
 	
   
 	
   
 	
  

  
	
   
  	
  
Section   10.05.
  	
  
Assignment
  	
  
25
  
	
  
 
  	
  
Section   10.06.
  	
  
Amendment;   No Waiver
  	
  
25
  
	
  
 
  	
  
Section   10.07.
  	
  
Entire   Agreement
  	
  
26
  
	
  
 
  	
  
Section   10.08.
  	
  
Severability
  	
  
26
  
	
  
 
  	
  
Section   10.09.
  	
  
Title and   Subtitles
  	
  
26
  
	
  
 
  	
  
Section   10.10.
  	
  
Counterparts
  	
  
26
  
	
   
  	
  
Section   10.11.
  	
  
Choice of   Law
  	
  
26
  
	
  
 
  	
  
Section   10.12.
  	
  
Specific   Enforcement, Consent to Jurisdiction
  	
  
26
  
	
  
 
  	
  
Section   10.13.
  	
  
Survival
  	
  
26
  
	
  
 
  	
  
Section   10.15.
  	
  
Further   Assurances
  	
  
27
  

v

COMMON STOCK PURCHASE AGREEMENT

by and between

KINGSBRIDGE CAPITAL LIMITED

and

EMISPHERE TECHNOLOGIES, INC.

dated as of December 27, 2004

          This COMMON STOCK PURCHASE AGREEMENT is entered into as of the 27th day of December, 2004 (this “Agreement”), by and between KINGSBRIDGE CAPITAL LIMITED, an entity organized and existing under the laws of the British Virgin Islands (the “Investor”) and EMISPHERE TECHNOLOGIES, INC., a corporation organized and existing under the laws of the State of Delaware (the “Company”).

          WHEREAS, the parties desire that, upon the terms and subject to the conditions set forth herein, the Company may issue and sell to the Investor, from time to time as provided herein, and the Investor shall purchase from the Company, up to $20 million worth of shares of Common Stock  (as defined below); and

          WHEREAS, such investments will be made in reliance upon the provisions of Section 4(2) (“Section 4(2)”) and Regulation D (“Regulation D”) of the United States Securities Act of 1933, as amended and the rules and regulations promulgated thereunder (the “Securities Act”), and/or upon such other exemption from the registration requirements of the Securities Act as may be available with respect to any or all of the investments in Common Stock to be made hereunder; and

          WHEREAS, the parties hereto are concurrently entering into a Registration Rights Agreement in the form of Exhibit A hereto (the “Registration Rights Agreement”) pursuant to which the Company shall register the Common Stock issued and sold to the Investor under this Agreement and under the Warrant (as defined below), upon the terms and subject to the conditions set forth therein; and

          WHEREAS, in consideration for the Investor’s execution and delivery of, and its performance of its obligations under, this Agreement, the Company is concurrently issuing to the Investor a Warrant in the form of Exhibit B hereto (the “Warrant”) pursuant to which the Investor may purchase from the Company up to 250,000 shares of Common Stock, upon the terms and subject to the conditions set forth therein;

          NOW, THEREFORE, the parties hereto agree as follows:

ARTICLE I

DEFINITIONS

          Section 1.01.     “Articles” shall have the meaning assigned to such term in Section 4.03 hereof.

          Section 1.02.     “Blackout Amount” shall have the meaning assigned to such term in the Registration Rights Agreement.

          Section 1.03.     “Blackout Shares” shall have the meaning assigned to such term in the Registration Rights Agreement.

          Section 1.04.     “Closing Date” means the date on which this Agreement is executed and delivered by the Company and the Investor.

          Section 1.05.     “Commission” means the United States Securities Exchange Commission.

          Section 1.06.     “Commission Documents” shall have the meaning assigned to such term in Section 4.06 hereof.

          Section 1.07.     “Commitment Period” means the period commencing on the Effective Date and expiring on the earliest to occur of (x) the date on which the Investor shall have purchased Shares pursuant to this Agreement for an aggregate purchase price equal to the Maximum Commitment Amount, (y) the date this Agreement is terminated pursuant to Article VIII hereof, and (z) the date occurring 24 months from the Effective Date.

          Section 1.08.     “Common Stock” means the common stock of the Company, par value $.01 per share.

          Section 1.09.     “Condition Satisfaction Date” shall have the meaning assigned to such term in Article VII hereof.

          Section 1.10.     “Damages” means any loss, claim, damage, liability, costs and expenses (including, without limitation, reasonable attorneys’ fees and expenses and costs and reasonable expenses of expert witnesses and investigation).

          Section 1.11.     “Draw Down” shall have the meaning assigned to such term in Section 3.01 hereof.

          Section 1.12.     “Draw Down Amount” means the actual amount of a Draw Down paid to the Company.

          Section 1.13.     “Draw Down Discount Price” means (i) 88% of the VWAP on any Trading Day during the Draw Down Pricing Period when the VWAP equals to or exceeds $2.00 but is less than $4.00; (ii) 90% of the VWAP on any Trading Day during the Draw Down Pricing Period when the VWAP equals to or exceeds $4.00 but is less than $8.50; or (iii) 92% of the VWAP on any Trading Day during the Draw Down Pricing Period when the VWAP is equal to or exceeds $8.50.

2

          Section 1.14.     “Draw Down Notice” shall have the meaning assigned to such term in Section 3.01 hereof.

          Section 1.15.     “Draw Down Pricing Period” shall mean, with respect to each Draw Down, a period of fifteen (15) consecutive Trading Days beginning on the first Trading Day specified in a Draw Down Notice.

          Section 1.16.     “Effective Date” means the first Trading Day immediately following the date on which the Registration Statement is declared effective by the Commission.

          Section 1.17.     “Exchange Act” means the U.S. Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

          Section 1.18.     “Excluded Merger or Sale” shall have the meaning assigned to such term in the Warrant.

          Section 1.19.     “Knowledge” means the actual knowledge of the Chief Executive Officer, Chief Financial Officer or any Senior Vice President or Vice President of the Company.

          Section 1.20.     “Make Whole Amount” shall have the meaning specified in Section 3.10.

          Section 1.21.     “Market Capitalization” means, as of any Trading Day, the product of (i) the closing sale price of the Company’s Common Stock as reported by Bloomberg L.P. using the AQR function and (ii) the number of outstanding shares of Common Stock of the Company as reported by Bloomberg L.P. using the DES function.

          Section 1.22.     “Material Adverse Effect” means any effect on the business, operations, properties or financial condition of the Company and its consolidated subsidiaries that is material and adverse to the Company and such subsidiaries, taken as a whole, and/or any condition, circumstance, or situation that would prohibit or otherwise interfere with the ability of the Company to perform any of its obligations under this Agreement, the Registration Rights Agreement or the Warrant in any material respect; provided, that none of the following shall constitute a “Material Adverse Effect”:  (i) the effects of conditions or events that are generally applicable to the capital, financial, banking or currency markets, (ii) any changes or effects resulting from the announcement or consummation of the transactions contemplated by this
Agreement, including, without limitation, any changes or effects associated with any particular Draw Down, and (iii) changes in the market price of the Company’s Common Stock.

          Section 1.23.     “Maximum Commitment Amount” means $20 million in aggregate Draw Down Amounts.

          Section 1.24.     “Maximum Draw Down Amount” means 3% of the Company’s Market Capitalization at the time of the Draw Down.

          Section 1.25.     “NASD” means the National Association of Securities Dealers, Inc.

          Section 1.26.     “Permitted Transaction” shall have the meaning assigned to such term in Section 6.07 hereof.

3

          Section 1.27.     “Person” means any individual, corporation, partnership, limited liability company, association, trust or other entity or organization, including any government or political subdivision or an agency or instrumentality thereof.

          Section 1.28.     “Principal Market” means the Nasdaq National Market, the Nasdaq SmallCap Market, the American Stock Exchange or the New York Stock Exchange, whichever is at the time the principal trading exchange or market for the Common Stock.

          Section 1.29.     “Prohibited Transaction” shall have the meaning assigned to such term in Section 6.08 hereof.

          Section 1.30.     “Prospectus” as used in this Agreement means the prospectus in the form included in the Registration Statement, as supplemented from time to time pursuant to Rule 424(b) of the Securities Act.

          Section 1.31.     “Registrable Securities” means (i) the Shares, (ii) the Warrant Shares, and (iii) any securities issued or issuable with respect to any of the foregoing by way of exchange, stock dividend or stock split or in connection with a combination of shares, recapitalization, merger, consolidation or other reorganization or otherwise.  As to any particular Registrable Securities, once issued such securities shall cease to be Registrable Securities when (w) the Registration Statement has been declared effective by the SEC and such Registrable Securities have been disposed of pursuant to the Registration Statement, (x) such Registrable Securities have been sold under circumstances under which all of the applicable conditions of Rule 144 (or any similar provision then in force) under the Securities Act (“Rule
144”) are met, (y) such time as such Registrable Securities have been otherwise transferred to holders who may trade such shares without restriction under the Securities Act, and the Company has delivered a new certificate or other evidence of ownership for such securities not bearing a restrictive legend or (z) in the opinion of counsel to the Company such Registrable Securities may be sold without registration and without any time, volume or manner limitations pursuant to Rule 144(k) (or any similar provision then in effect) under the Securities Act.

          Section 1.32.     “Registration Rights Agreement” shall have the meaning set forth in the recitals of this Agreement.

          Section 1.33.     “Registration Statement” shall have the meaning assigned to such term in the Registration Rights Agreement.

          Section 1.34.     “Regulation D” shall have the meaning set forth in the recitals of this Agreement.

          Section 1.35.     “Section 4(2)” shall have the meaning set forth in the recitals of this Agreement.

          Section 1.36.     “Securities Act” shall have the meaning set forth in the recitals of this Agreement.

          Section 1.37.     “Settlement Date” shall have the meaning assigned to such term in Section 3.06 hereof.

          Section 1.38.     “Shares” means the shares of Common Stock of the Company that are and/or may be purchased hereunder.

4

          Section 1.39.     “Threshold Price” means the lowest “Draw Down Discount Price” (as specified by the Company in a Draw Down Notice) at which the Company will agree to sell Shares during the applicable Draw Down Pricing Period, which price shall not be set in respect of any Draw Down Pricing Period at less than $2.00 per share.

          Section 1.40.     “Trading Day” means any day other than a Saturday or a Sunday on which the Principal Market is open for trading in equity securities.

          Section 1.41.     “VWAP” means the volume weighted average price (the aggregate sales price of all trades of Common Stock during each Trading Day divided by the total number of shares of Common Stock traded during such Trading Day) of the Common Stock during any Trading Day as reported by Bloomberg, L.P. using the AQR function. 

          Section 1.42.     “Warrant” shall have the meaning set forth in the recitals of this Agreement.

          Section 1.43.     “Warrant Shares” means the shares of Common Stock issuable to the Investor upon exercise of the Warrant.

ARTICLE II

PURCHASE AND SALE OF COMMON STOCK

          Section 2.01.     Purchase and Sale of Stock.  Upon the terms and subject to the conditions set forth in this Agreement, the Company shall to the extent of Draw Downs in accordance with Article III hereof, issue and sell to the Investor and the Investor shall purchase from the Company Common Stock for an aggregate (in Draw Down Amounts) of up to the Maximum Commitment Amount, consisting of purchases based on Draw Downs in accordance with Article III hereof.

          Section 2.02.     Closing.  In consideration of and in express reliance upon the representations, warranties, covenants, terms and conditions of this Agreement, the Company agrees to issue and sell to the Investor, and the Investor agrees to purchase from the Company, that number of the Shares to be issued in connection with each Draw Down.  The closing of the execution and delivery of this Agreement (the “Closing”) shall take place at the offices of Clifford Chance US LLP, 31 West 52nd Street, New York, NY 10019 at 2:00 p.m. local time on December 27, 2004, or at such other time and place or on such date as the Investor and the Company may agree upon (the “Closing Date”).  Each party shall deliver all documents, instruments and writings required to be delivered by such party pursuant to this Agreement at or prior
to the Closing.

          Section 2.03.     Registration Statement and Prospectus.  Promptly after the Closing, the Company shall prepare and file with the Commission the Registration Statement (including the Prospectus) in accordance with the provisions of the Securities Act and the Registration Rights Agreement.

          Section 2.04.     Warrant.  On the Closing Date, the Company shall issue and deliver the Warrant to the Investor.

5

          Section 2.05.     Blackout Shares.  The Company shall deliver any Blackout Amount or issue and deliver any Blackout Shares to the Investor in accordance with Section 1(e) of the Registration Rights Agreement.

ARTICLE III

DRAW DOWN TERMS

          Subject to the satisfaction of the conditions hereinafter set forth in this Agreement, the parties agree as follows:

          Section 3.01.     Draw Down Notice.  The Company, may, in its sole discretion, issue a Draw Down Notice with respect to a Draw Down up to a Draw Down Amount equal to the Maximum Draw Down Amount (each, a “Draw Down”) during the Commitment Period, which Draw Down the Investor will be obligated to accept.  The Company shall inform the Investor via facsimile transmission, with a copy to the Investor’s counsel, as to the Draw Down Amount the Company wishes to exercise before commencement of trading on the first Trading Day of any Draw Down Pricing Period (the “Draw Down Notice”).  In addition to the Draw Down Amount, each Draw Down Notice shall specify the Threshold Price in respect of the applicable Draw Down and shall designate the first Trading Day of the Draw Down Pricing Period.  In no event shall any Draw Down
Amount exceed the Maximum Draw Down Amount.  Each Draw Down Notice shall be accompanied by a certificate, signed by the Chief Executive Officer or Chief Financial Officer dated, as of the date of such Draw Down Notice, in the form of Exhibit C hereof.

          Section 3.02.     Number of Shares.  The number of Shares to be issued in connection with each Draw Down shall be equal to the sum of the quotients (for each Trading Day of the Draw Down Pricing Period for which the Draw Down Discount Price equals or exceeds the Threshold Price) of one fifteenth (1/15th) of the Draw Down Amount divided by the applicable Draw Down Discount Price.

          Section 3.03.     Limitation on Draw Downs.  Only one Draw Down shall be permitted for each Draw Down Pricing Period.

          Section 3.04.     Trading Cushion.  Unless the parties agree in writing otherwise, there shall be a minimum of five (5) Trading Days between the expiration of any Draw Down Pricing Period and the beginning of the next succeeding Draw Down Pricing Period.

          Section 3.05.     Expiration of Draw Downs.  Each Draw Down will expire on the last Trading Day of each Draw Down Pricing Period.

          Section 3.06.     Settlement.  The number of Shares purchased by the Investor with respect to each Draw Down shall be determined and settled on a periodic basis in respect of the applicable Draw Down Pricing Period.  Settlement in respect of each determination shall be made no later than the third Trading Day after the fifth, tenth and fifteenth Trading Day of the Draw Down Pricing Period.  Each date on which settlement of the purchase and sale of Shares occurs hereunder being referred to as a “Settlement Date.”  The Investor shall provide the Company with delivery instructions for the Shares to be issued at each Settlement Date at least two Trading Days in advance of such Settlement Date (except to the extent previously provided).  The number of Shares actually issued shall be rounded to the nearest whole number of
Shares.

6

          Section 3.07.     Delivery of Shares; Payment of Draw Down Amount.  On each Settlement Date, the Company shall deliver the Shares purchased by the Investor to the Investor or its designees via book-entry through the Depositary Trust Company (DWAC) to an account designated by the Investor, and upon receipt of the Shares, the Investor shall cause payment therefor to be made to the Company’s designated account by wire transfer of immediately available funds, if the Shares are delivered to the Investor or its designee no later than 1:00 p.m. (Eastern Time), or next day available funds, if the Shares are delivered thereafter.

          Section 3.08.     Threshold Price.  For each Trading Day during a Draw Down Pricing Period that the Draw Down Discount Price is less than the Threshold Price, no Shares shall be purchased or sold in respect of such Trading Day and the total amount of the Draw Down Amount in respect of such Draw Down Pricing Period shall be reduced by one fifteenth (1/15th).  If trading in the Company’s Common Stock is suspended for any reason for more than three (3) consecutive or non-consecutive hours during any Trading Day during a Draw Down Pricing Period, the Draw Down Discount Price shall be deemed to be less than the Threshold Price for that Trading Day.

          Section 3.09.     Other Issuances.  If during any Draw Down Pricing Period the Company shall (with the consent of the Investor pursuant to Section 6.07 or 6.08 hereof, if applicable) issue any shares of Common Stock to any Person other than the Investor (other than shares of Common Stock issued in connection with a Permitted Transaction), then the applicable Draw Down Notice shall be deemed null and void and the Investor shall promptly return to the Company any and all Shares transferred to the Investor in respect of any Settlement Date(s) during such Draw Down Pricing Period and the Company shall promptly thereafter pay to the Investor by wire transfer of immediately available funds to an account designated by the Investor that portion of the applicable Draw Down Amount paid to the Company in respect of such Settlement Date(s).

          Section 3.10.     Failure to Deliver Shares.  If on any Settlement Date, the Company fails to deliver the Shares to be purchased by the Investor, and such failure is not cured within ten (10) Trading Days following the date on which the Investor delivered payment for such Shares, the Company shall pay to the Investor on demand in cash by wire transfer of immediately available funds to an account designated by the Investor the “Make Whole Amount;” provided, however, that in the event that the Company is prevented from delivering Shares in respect of any such Settlement Date in a timely manner by any fact or circumstance that is reasonably within the control of, or directly attributable to, the Investor, then such ten (10) Trading Day period shall be automatically extended until such time as such fact or circumstance is cured.  As
used herein, the Make Whole Amount shall be an amount equal to the sum of (i) the Draw Down Amount actually paid by the Investor in respect of such Shares plus (ii) an amount equal to the actual loss suffered by the Investor in respect of sales to subsequent purchasers, pursuant to transactions entered into before the Settlement Date, of the Shares that were required to be delivered by the Company, which shall be based upon documentation reasonably satisfactory to the Company demonstrating the difference (if greater than zero) between (A) the price per share paid by the Investor to purchase such number of shares of Common Stock necessary for the Investor to meet its share delivery obligations to such subsequent purchasers minus (B) the average Draw Down Discount Price during the applicable Draw Down Pricing Period.  In the event that the Make Whole Amount is not paid within two (2) Trading Days following a demand therefor from the Investor, the Make Whole Amount shall accrue interest
compounded daily at a rate of five percent (5%) per annum up to and including the date on which the Make Whole Amount is actually paid.  Notwithstanding anything to the contrary set forth in this Agreement, in the event that the Company pays the Make Whole Amount (plus interest, if applicable) in respect of any Settlement Date in accordance with this Section 3.10, such payment shall be the Investor’s sole remedy in respect of the Company’s failure to deliver Shares in respect of such Settlement Date, and the Company shall not be obligated to deliver such Shares.

7

ARTICLE IV

REPRESENTATIONS AND WARRANTIES OF THE COMPANY

          The Company hereby makes the following representations and warranties to the Investor:

          Section 4.01.     Organization, Good Standing and Power.  The Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware and has all requisite power and authority to own, lease and operate its properties and to carry on its business as now being conducted.  Except as set forth in the Commission Documents (as defined below), the Company does not own more than fifty percent (50%) of the outstanding capital stock of or control any other business entity, other than any wholly-owned subsidiary that is not “significant” within the meaning of Regulation S-X promulgated by the Commission.  The Company is duly qualified as a foreign corporation to do business and is in good standing in every jurisdiction in which the nature of the business conducted or property owned by it makes such qualification
necessary, other than those in which the failure so to qualify or be in good standing would not have a Material Adverse Effect.

          Section 4.02.     Authorization; Enforcement.  (i) The Company has the requisite corporate power and authority to enter into and perform its obligations under this Agreement, the Registration Rights Agreement and the Warrant and to issue the Shares, the Warrant, the Warrant Shares and any Blackout Shares (except to the extent that the number of Blackout Shares required to be issued exceeds the number of authorized shares of Common Stock under the Articles); (ii) the execution and delivery of this Agreement and the Registration Rights Agreement, and the execution, issuance and delivery of the Warrant, by the Company and the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary corporate action and no further consent or authorization of the Company or its Board of Directors or stockholders is required
(other than as contemplated by Section 6.05); and (iii) each of this Agreement and the Registration Rights Agreement has been duly executed and delivered, and the Warrant has been duly executed, issued and delivered, by the Company and constitute the valid and binding obligations of the Company enforceable against the Company in accordance with their respective terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, or similar laws relating to, or affecting generally the enforcement of, creditors’ rights and remedies or by other equitable principles of general application.

          Section 4.03.     Capitalization.  The authorized capital stock of the Company and the shares thereof issued and outstanding as of September 30, 2004 are set forth on a Schedule previously delivered to the Investor.  All of the outstanding shares of the Common Stock have been duly and validly authorized and issued, and are fully paid and non-assessable.  Except as set forth in this Agreement or as previously disclosed to the Investor in writing, as of the date hereof no shares of Common Stock are entitled to preemptive rights or registration rights and there are no outstanding options, warrants, scrip, rights to subscribe to, call or commitments of any character whatsoever relating to, or securities or rights convertible into or exchangeable for or giving any right to subscribe for, any shares of capital stock of the Company.  Except as set forth in
this Agreement, the Commission Documents, or as previously disclosed to the Investor in writing, as of the date hereof, there are no contracts, commitments, understandings, or arrangements by which the Company is or may become bound to issue additional shares of the capital stock of the Company or options, securities or rights convertible into or exchangeable for 

8

or giving any right to subscribe for any shares of capital stock of the Company.  Except as previously disclosed to the Investor in writing, as of the date hereof the Company is not a party to any agreement granting registration rights to any Person with respect to any of its equity or debt securities.  Except as set forth in the Commission Documents or as previously disclosed to the Investor in writing, as of the date hereof the Company is not a party to, and it has no Knowledge of, any agreement restricting the voting or transfer of any shares of the capital stock of the Company.  The offer and sale of all capital stock, convertible securities, rights, warrants, or options of the Company issued during the twenty-four month period immediately prior to the Closing complied with all applicable federal and state securities laws, and no stockholder has a right of rescission or damages with respect thereto that could reasonably be expected to have a
Material Adverse Effect.  The Company has furnished or made available to the Investor true and correct copies of the Company’s Amended and Restated Articles of Incorporation, as amended and in effect on the date hereof (the “Articles”), and the Company’s Bylaws, as amended and in effect on the date hereof (the “Bylaws”).

          Section 4.04.     Issuance of Shares.  The Shares, the Warrant and the Warrant Shares have been, and any Blackout Shares will be, duly authorized by all necessary corporate action (except to the extent that the number of Blackout Shares required to be issued exceeds the number of authorized shares of Common Stock under the Articles) and, when issued and paid for in accordance with the terms of this Agreement, the Registration Rights Agreement and the Warrant, the Shares and the Warrant Shares shall be validly issued and outstanding, fully paid and non-assessable, and the Investor shall be entitled to all rights accorded to a holder of shares of Common Stock.

          Section 4.05.     No Conflicts.  The execution, delivery and performance of this Agreement, the Registration Rights Agreement, the Warrant and any other document or instrument contemplated hereby or thereby, by the Company and the consummation by the Company of the transactions contemplated hereby and thereby do not:  (i) violate any provision of the Articles or Bylaws, (ii) conflict with, or constitute a default (or an event which with notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, any material agreement, mortgage, deed of trust, indenture, note, bond, license, lease agreement, instrument or obligation to which the Company is a party, (iii) create or impose a lien, charge or encumbrance on any property of the Company under any agreement or any
commitment to which the Company is a party or by which the Company is bound or by which any of its respective properties or assets are bound, (iv) result in a violation of any federal, state, local or foreign statute, rule, regulation, order, writ, judgment or decree (including federal and state securities laws and regulations) applicable to the Company or any of its subsidiaries or by which any property or asset of the Company or any of its subsidiaries are bound or affected, or (v) require any consent of any third-party that has not been obtained pursuant to any material contract to which the Company is subject or to which any of its assets, operations or management may be subject.  The Company is not required under federal, state or local law, rule or regulation to obtain any consent, authorization or order of, or make any filing or registration with, any court or governmental agency in order for it to execute, deliver or perform any of its obligations under this Agreement, the
Registration Rights Agreement or the Warrant, or issue and sell the Shares, the Warrant Shares or the Blackout Shares (except to the extent that the number of Blackout Shares required to be issued exceeds the number of authorized shares of Common Stock under the Articles) in accordance with the terms hereof and thereof (other than any filings that may be required to be made by the Company with the Commission, the NASD/Nasdaq or state securities commissions subsequent to the Closing, and, any registration statement (including any amendment or supplement thereto) which may be filed pursuant hereto); provided that, for purposes of the representation made in this sentence, the Company is assuming and relying upon the accuracy of the relevant representations and agreements of the Investor herein.

9

          Section 4.06.     Commission Documents, Financial Statements.  The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, since December 31, 2002 and the Company has timely filed all reports, schedules, forms, statements and other documents required to be filed by it with the Commission pursuant to the reporting requirements of the Exchange Act, including material filed pursuant to Section 13(a) or 15(d) of the Exchange Act (all of the foregoing, including filings incorporated by reference therein, being referred to herein as the “Commission Documents”).  Except as previously disclosed to the Investor in writing, since December 31, 2002 the Company has maintained all requirements for the continued listing or quotation of its Common Stock, and such Common Stock is currently listed or quoted on the Nasdaq
National Market.  The Company has made available to the Investor true and complete copies of the Commission Documents filed with the Commission since December 31, 2002 and prior to the Closing Date.  The Company has not provided to the Investor any information which, according to applicable law, rule or regulation, should have been disclosed publicly by the Company but which has not been so disclosed, other than with respect to the transactions contemplated by this Agreement.  As of its date, the Company’s Form 10-K for the year ended December 31, 2003 complied in all material respects with the requirements of the Exchange Act and the rules and regulations of the Commission promulgated thereunder applicable to such document, and, as of its date, after giving effect to the information disclosed and incorporated by reference therein, such Form 10-K did not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in
order to make the statements therein, in light of the circumstances under which they were made, not misleading.  As of their respective dates, the financial statements of the Company included in the Commission Documents filed with the Commission since December 31, 2002 complied as to form and substance in all material respects with applicable accounting requirements and the published rules and regulations of the Commission or other applicable rules and regulations with respect thereto.  Such financial statements have been prepared in accordance with generally accepted accounting principles (“GAAP”) applied on a consistent basis during the periods involved (except (i) as may be otherwise indicated in such financial statements or the notes thereto or (ii) in the case of unaudited interim statements, to the extent they may not include footnotes or may be condensed or summary statements), and fairly present in all material respects the financial position of the Company
and its subsidiaries as of the dates thereof and the results of operations and cash flows for the periods then ended (subject, in the case of unaudited statements, to normal year-end audit adjustments).

          Section 4.07.     No Material Adverse Change.  Except as disclosed in the Commission Documents, since December 31, 2003 no event or series of events has or have occurred that would, individually or in the aggregate, have a Material Adverse Effect on the Company.

          Section 4.08.     No Undisclosed Liabilities.  Neither the Company nor any of its subsidiaries has any liabilities, obligations, claims or losses (whether liquidated or unliquidated, secured or unsecured, absolute, accrued, contingent or otherwise) that would be required to be disclosed on a balance sheet of the Company or any subsidiary (including the notes thereto) in conformity with GAAP and are not disclosed in the Commission Documents, other than those incurred in the ordinary course of the Company’s or its subsidiaries respective businesses since December 31, 2003 and which, individually or in the aggregate, do not or would not have a Material Adverse Effect on the Company.

10

          Section 4.09.     No Undisclosed Events or Circumstances.  No event or circumstance has occurred or exists with respect to the Company or its subsidiaries or their respective businesses, properties, operations or financial condition, which, under applicable law, rule or regulation, requires public disclosure or announcement by the Company but which has not been so publicly announced or disclosed and which, individually or in the aggregate, would have a Material Adverse Effect on the Company.

          Section 4.10.     Actions Pending.  There is no action, suit, claim, investigation or proceeding pending or, to the Knowledge of the Company, threatened against the Company or any subsidiary which questions the validity of this Agreement or the transactions contemplated hereby or any action taken or to be taken pursuant hereto or thereto. Except as set forth in the Commission Documents or as previously disclosed to the Investor in writing, there is no action, suit, claim, investigation or proceeding pending or, to the Knowledge of the Company, threatened, against or involving the Company, any subsidiary or any of their respective properties or assets that could be reasonably expected to have a Material Adverse Effect on the Company.  Except as set forth in the Commission Documents or as previously disclosed to the Investor in writing, no judgment, order, writ,
injunction or decree or award has been issued by or, to the Knowledge of the Company, requested of any court, arbitrator or governmental agency which could be reasonably expected to result in a Material Adverse Effect.

          Section 4.11.     Compliance with Law.  The businesses of the Company and its subsidiaries have been and are presently being conducted in accordance with all applicable federal, state and local governmental laws, rules, regulations and ordinances, except as set forth in the Commission Documents or such that would not reasonably be expected to cause a Material Adverse Effect.  Except as set forth in the Commission Documents, the Company and each of its subsidiaries have all franchises, permits, licenses, consents and other governmental or regulatory authorizations and approvals necessary for the conduct of its business as now being conducted by it, except for such franchises, permits, licenses, consents and other governmental or regulatory authorizations and approvals, the failure to possess which, individually or in the aggregate, could not reasonably be
expected to have a Material Adverse Effect.

          Section 4.12.     Certain Fees.  Except as expressly set forth in this Agreement, no brokers, finders or financial advisory fees or commissions will be payable by the Company or any of its subsidiaries in respect of the transactions contemplated by this Agreement.

          Section 4.13.     Disclosure.  To the Company’s Knowledge, neither this Agreement nor any other documents, certificates or instruments furnished to the Investor by or on behalf of the Company or any subsidiary in connection with the transactions contemplated by this Agreement contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements made herein or therein, in the light of the circumstances under which they were made herein or therein, not misleading.

          Section 4.14.     Material Non-Public Information.  Except for this Agreement and the transactions contemplated hereby, neither the Company nor its agents have disclosed to the Investor, any material non-public information that, according to applicable law, rule or regulation, should have been disclosed publicly by the Company prior to the date hereof but which has not been so disclosed.

          Section 4.15.     Exemption from Registration; Valid Issuances.  The issuance and sale of the Shares, the Warrant, the Warrant Shares and any Blackout Shares in accordance with the terms and on the bases of the representations and warranties set forth in this Agreement, may and 

11

shall be properly issued pursuant to Section 4(2), Regulation D and/or any other applicable federal and state securities laws.  Neither the sales of the Shares, the Warrant, the Warrant Shares or any Blackout Shares pursuant to, nor the Company’s performance of its obligations under, this Agreement, the Registration Rights Agreement, or the Warrant shall (i) result in the creation or imposition of any liens, charges, claims or other encumbrances upon the Shares, the Warrant Shares, any Blackout Shares or any of the assets of the Company, or (ii) except as previously disclosed to the Investor in writing, entitle the holders of any outstanding shares of capital stock of the Company to preemptive or other rights to subscribe to or acquire the shares of Common Stock or other securities of the Company.  The Shares, the Warrant Shares and any Blackout Shares shall not subject the Investor to personal liability to the Company, its officers,
directors, employees or stockholders by reason of the ownership thereof.

          Section 4.16.     No General Solicitation or Advertising in Regard to this Transaction.  Neither the Company nor any of its affiliates or any person acting on its or their behalf (i) has conducted any general solicitation (as that term is used in Rule 502(c) of Regulation D) or general advertising with respect to any of the Shares, the Warrant, the Warrant Shares or any Blackout Shares or (ii) has made any offers or sales of any security or solicited any offers to buy any security under any circumstances that would require registration of the Shares under the Securities Act.

          Section 4.17.     No Integrated Offering.  Neither the Company, nor any of its affiliates, nor any person acting on its or their behalf has, directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security, other than pursuant to this Agreement and employee benefit plans, under circumstances that would require registration under the Securities Act of shares of the Common Stock issuable hereunder with any other offers or sales of securities of the Company.

          Section 4.18.     Acknowledgment Regarding Investor’s Purchase of Shares.  The Company acknowledges and agrees that the Investor is acting solely in the capacity of an arm’s length Investor with respect to this Agreement and the transactions contemplated hereunder.  The Company further acknowledges that the Investor is not acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with respect to this Agreement and the transactions contemplated hereunder and any advice given by the Investor or any of its representatives or agents in connection with this Agreement and the transactions contemplated hereunder is merely incidental to the Investor’s purchase of the Shares.

ARTICLE V

REPRESENTATIONS, WARRANTIES AND COVENANTS OF THE INVESTOR

          The Investor hereby makes the following representations, warranties and covenants to the Company:

          Section 5.01.     Organization and Standing of the Investor.  The Investor is a company duly organized, validly existing and in good standing under the laws of the British Virgin Islands.

          Section 5.02.     Authorization and Power.  The Investor has the requisite power and authority to enter into and perform its obligations under this Agreement and the Registration Rights Agreement and to purchase the Shares in accordance with the terms hereof.  The execution, delivery and performance of this Agreement and the Registration Rights Agreement by Investor and the consummation by it of the transactions contemplated hereby or thereby have 

12

been duly authorized by all necessary corporate action, and no further consent or authorization of the Investor, its Board of Directors or stockholders is required.  Each of this Agreement and the Registration Rights Agreement has been duly executed and delivered by the Investor and constitutes a valid and binding obligation of the Investor enforceable against the Investor in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, liquidation, conservatorship, receivership, or similar laws relating to, or affecting generally the enforcement of creditor’s rights and remedies or by other equitable principles of general application.

          Section 5.03.     No Conflicts.  The execution, delivery and performance of this Agreement, Registration Rights Agreement and any other document or instrument contemplated hereby, by the Investor and the consummation of the transactions contemplated thereby do not (i) violate any provision of the Investor’s charter documents or bylaws, (ii) conflict with, or constitute a default (or an event which with notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, any material agreement, mortgage, deed of trust, indenture, note, bond, license, lease agreement, instrument or obligation to which the Investor is a party, (iii) create or impose a lien, charge or encumbrance on any property of the Investor under any agreement or any commitment to which the
Investor is a party or by which the Investor is bound or by which any of its respective properties or assets are bound, (iv) result in a violation of any federal, state, local or foreign statute, rule, regulation, order, writ, judgment or decree (including federal and state securities laws and regulations) applicable to the Investor or by which any property or asset of the Investor are bound or affected, or (v) require the consent of any third-party that has not been obtained pursuant to any material contract to which Investor is subject or to which any of its assets, operations or management may be subject.  The Investor is not required under federal, state or local law, rule or regulation to obtain any consent, authorization or order of, or make any filing or registration with, any court or governmental agency in order for it to execute, deliver or perform any of its obligations under this Agreement or to purchase the Shares in accordance with the terms hereof, provided that,
for purposes of the representation made in this sentence, the Investor is assuming and relying upon the accuracy of the relevant representations and agreements of the Company herein.

          Section 5.04.     Financial Capability.  The Investor has the financial capability to perform all of its obligations under this Agreement, including the capability to purchase the Shares in accordance with the terms hereof.  The Investor has such knowledge and experience in business and financial matters that it is capable of evaluating the merits and risks of an investment in Common Stock.  The Investor is an “accredited investor” as defined in Regulation D.  The Investor is a “sophisticated investor” as described in Rule 506(b)(2)(ii) of Regulation D.  The Investor acknowledges that an investment in the Common Stock is speculative and involves a high degree of risk.

          Section 5.05.     Information.  The Investor and its advisors, if any, have been furnished with all materials relating to the business, finances and operations of the Company and materials relating to the offer and sale of the Shares which have been requested by the Investor.  The Investor has reviewed or received copies of the Commission Documents. The Investor and its advisors, if any, have been afforded the opportunity to ask questions of the Company.  The Investor has sought such accounting, legal and tax advice as it has considered necessary to make an informed investment decision with respect to its acquisition of the Shares.  The Investor understands that it (and not the Company) shall be responsible for its own tax liabilities that may arise as a result of this investment or the transactions contemplated by this Agreement.

13

          Section 5.06.     Selling Restrictions.

          (a)     The Investor covenants that during the Commitment Period, neither the Investor nor any of its affiliates nor any entity managed by the Investor will ever (i) be in a short position with respect to shares of the Common Stock in any accounts directly or indirectly managed by the Investor or any affiliate of the Investor or any entity managed by the Investor or (ii) engage in any transaction intended to reduce the economic risk of ownership of shares of Common Stock (including, without limitation, the purchase of any option or contract to sell) that would, directly or indirectly, have an effect substantially equivalent to selling short such shares of Common Stock that are subject to, underlie or may be deliverable in satisfaction of such transaction or otherwise may be reasonably be expected to adversely affect the market price of the Common Stock. 
Notwithstanding the foregoing, the Investor shall have the right during any Draw Down Pricing Period to sell shares of the Company’s Common Stock equal in number to the aggregate number of Shares that have been determined will be required to be delivered on a Settlement Date pursuant to Article III hereof.

          (b)     The Investor’s trading activities with respect to shares of the Company’s Common Stock will be in compliance in all material respects with all applicable state and federal securities laws, rules and regulations and the rules and regulations of the Principal Market on which the Company’s Common Stock is listed.

          Section 5.07.     Statutory Underwriter Status.  The Investor acknowledges and agrees that, pursuant to the Commission’s current interpretations of the Securities Act, the Investor will be disclosed as an “underwriter” within the meaning of the Securities Act in the Registration Statement (and amendments thereto) and in any Prospectus contained therein to the extent required by applicable law.

          Section 5.08.     Not an Affiliate.  The Investor is not an officer, director or “affiliate” (as defined in Rule 405 of the Securities Act) of the Company.

          Section 5.09.     Manner of Sale.  At no time was Investor presented with or solicited by or through any leaflet, public promotional meeting, television advertisement or any other form of general solicitation or advertising.

ARTICLE VI

COVENANTS OF THE COMPANY

          The Company covenants with the Investor as follows, which covenants are for the benefit of the Investor and its permitted assignees (as defined herein):

          Section 6.01.     Securities.  The Company shall notify the Commission and the Principal Market, if and as applicable, in accordance with their rules and regulations, of the transactions contemplated by this Agreement, and shall use commercially reasonable efforts to take all other necessary action and proceedings as may be required and permitted by applicable law, rule and regulation, for the legal and valid issuance of the Shares, the Warrant Shares and the Blackout Shares, if any, to the Investor.

          Section 6.02.     Reservation of Common Stock.  As of the date hereof, the Company has available and the Company shall reserve and keep available at all times, free of preemptive rights and other similar contractual rights of stockholders, shares of Common Stock for the purpose of 

14

enabling the Company to satisfy any obligation to issue the Shares in connection with all Draw Downs contemplated hereunder and the Warrant Shares.  The number of shares so reserved from time to time, as theretofore increased or reduced as hereinafter provided, may be reduced by the number of shares actually delivered hereunder.

          Section 6.03.     Registration and Listing.  During the Commitment Period, the Company shall use commercially reasonable efforts:  (i) to take all action necessary to cause its Common Stock to continue to be registered under Section 12(b) or 12(g) of the Exchange Act, (ii) to comply in all respects with its reporting and filing obligations under the Exchange Act, (iii) to prevent the termination or suspension of such registration, or the termination or suspension of its reporting and filing obligations under the Exchange Act or Securities Act (except as expressly permitted herein).  The Company shall use commercially reasonable efforts to maintain the listing and trading of its Common Stock and the listing of the Shares purchased by Investor hereunder on the Principal Market (including, without limitation, maintaining sufficient net
tangible assets) and will comply in all material respects with the Company’s reporting, filing and other obligations under the bylaws or rules of the NASD and the Principal Market.

          Section 6.04.     Registration Statement.  Without the prior written consent of the Investor, the Registration Statement shall be used solely in connection with the transactions between the Company and the Investor contemplated hereby.

          Section 6.05.     Compliance with Laws.

          (a)     The Company shall comply, and cause each subsidiary to comply, with all applicable laws, rules, regulations and orders, noncompliance with which could reasonably be expected to have a Material Adverse Effect.

          (b)     Without the consent of its stockholders in accordance with NASD rules, the Company will not be obligated to issue, and the Investor will not be obligated to purchase, any Shares which would result in the issuance under this Agreement of Shares representing more than the applicable percentage under the rules of the NASD that would require stockholder approval of the issuance thereof.

          Section 6.06.     Reporting Requirements.  Upon reasonable written request of the Investor during the Commitment Period, the Company shall furnish copies of the following to the Investor within three Trading Days of such request (but not sooner than filed with or submitted to the Commission):

          (a)     Quarterly Reports on Form 10-Q;

          (b)     Annual Reports on Form 10-K;

          (c)     Current Reports on Form 8-K; and

          (d)     any other documents publicly furnished or submitted to the Commission.

          Section 6.07.     Other Financing.  Nothing in this Agreement shall be construed to restrict the right of the Company to offer, sell and/or issue securities of any kind whatsoever, provided such transaction is not a Prohibited Transaction (as defined below) (any such transaction that is not a Prohibited Transaction is referred to in this Agreement as a “Permitted Transaction”).  Without limiting the generality of the preceding sentence, the Company may, without the prior 

15

written consent of the Investor, (i) establish stock option or award plans or agreements (for directors, employees, consultants and/or advisors), and issue securities thereunder, and amend such plans or agreements, including increasing the number of shares available thereunder, (ii) issue equity securities to finance, or otherwise in connection with, the acquisition of one or more other companies, equipment, technologies or lines of business, (iii) issue shares of Common Stock and/or Preferred Stock in connection with the Company’s option or award plans, stock purchase plans, rights plans, warrants or options, (iv) issue shares of Common Stock and/or Preferred Stock in connection with the acquisition of products, licenses, equipment or other assets and strategic partnerships or joint ventures (the primary purpose of which is not to raise equity capital); (v) issue shares of Common and/or Preferred Stock to consultants and/or advisors
as consideration for services rendered or to be rendered, (vi) issue and sell equity or debt securities in a public offering, (vii) issue and sell and equity or debt securities in a private placement (other than in connection with any Prohibited Transaction), (viii) issue equity securities to equipment lessors, equipment vendors, banks or similar lending institutions in connection with leases or loans, or in connection with strategic commercial or licensing transactions, (ix) issue securities in connection with any stock split, stock dividend, recapitalization, reclassification or similar event by the Company, and (x) issue shares of Common Stock to the Investor under any other agreement entered into between the Investor and the Company.  The Company shall use commercially reasonable efforts to notify the Investor in writing prior to the consummation of any material Permitted Transaction described in clauses (vi), (vii) or (ix) above.

          Section 6.08.     Prohibited Transactions.  During the term of this Agreement, the Company shall not enter into any Prohibited Transaction without the prior written consent of the Investor, which consent may be withheld at the sole discretion of the Investor.  For the purposes of this Agreement, the term “Prohibited Transaction” shall refer to the issuance by the Company of any “future priced securities,” which shall be deemed to mean the issuance of shares of Common Stock or securities of any type whatsoever that are, or may become, convertible or exchangeable into shares of Common Stock where the purchase, conversion or exchange price for such Common Stock is determined using any floating discount or other post-issuance adjustable discount to the market price of Common Stock, including, without limitation, pursuant to any equity line
or other financing that is substantially similar to the financing provided for under this Agreement.  

          Section 6.09.     Corporate Existence.  The Company shall take all steps necessary to preserve and continue the corporate existence of the Company; provided, however, that nothing in this Agreement shall be deemed to prohibit the Company from engaging in any Excluded Merger or Sale with another Person provided that in the event of an Excluded Merger or Sale, if the surviving, successor or purchasing Person does not agree to assume the obligations under the Warrant, then the Company shall deliver a notice to the Investor at least 10 (ten) days before the consummation of such Excluded Merger or Sale, the Investor may exercise the Warrant at any time before the consummation of such Excluded Merger or Sale (and such exercise may be made contingent upon the consummation of such Excluded Merger or Sale), and any portion of the Warrant that has not been
exercised before consummation of such Excluded Merger or Sale shall terminate and expire, and shall no longer be outstanding.

          Section 6.10.     Non-Disclosure of Non-Public Information.  Except as otherwise expressly provided in this Agreement, none of the Company, its officers, directors, employees nor agents shall disclose material non-public information to the Investor, its advisors or representatives.

16

          Section 6.11.     Notice of Certain Events Affecting Registration; Suspension of Right to Request a Draw Down.  The Company shall promptly notify the Investor upon the occurrence of any of the following events in respect of the Registration Statement or the Prospectus related to the offer, issuance and sale of the Shares and the Warrant Shares hereunder:  (i) receipt of any request for additional information by the Commission or any other federal or state governmental authority during the period of effectiveness of the Registration Statement for amendments or supplements to the Registration Statement or the Prospectus; (ii) the issuance by the Commission or any other federal or state governmental authority of any stop order suspending the effectiveness of the Registration Statement or the initiation of any proceedings for that purpose; and
(iii) receipt of any notification with respect to the suspension of the qualification or exemption from qualification of any of the Registrable Securities for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose.  The Company shall not request a Draw Down during the continuation of any of the foregoing events.

          Section 6.12.     Amendments to the Registration Statement.  When the Registration Statement is declared effective by the Commission, the Company shall (i) not file any amendment to the Registration Statement or make any amendment or supplement to the Prospectus of which the Investor shall not previously have been advised or to which the Investor shall reasonably object after being so advised and (ii) so long as, in the reasonable opinion of counsel for the Investor, a Prospectus is required to be delivered in connection with sales of the Shares by the Investor, if the Company files any information, documents or reports that are incorporated by reference in the Registration Statement pursuant to the Exchange Act, the Company shall deliver a copy of such information, documents or reports to the Investor promptly following such filing.

          Section 6.13.     Prospectus Delivery.  From time to time for such period as in the reasonable opinion of counsel for the Investor a prospectus is required by the Securities Act to be delivered in connection with sales by the Investor, the Company will expeditiously deliver to the Investor, without charge, as many copies of the Prospectus (and of any amendment or supplement thereto) as the Investor may reasonably request.  The Company consents to the use of the Prospectus (and of any amendment or supplement thereto) in accordance with the provisions of the Securities Act and state securities laws in connection with the offering and sale of the Shares and the Warrant Shares and for such period of time thereafter as the Prospectus is required by the Securities Act to be delivered in connection with sales of the Shares and the Warrant Shares.

          Section 6.14.     Expectations Regarding Draw Downs.  Within ten (10) calendar days after the commencement of each calendar quarter occurring subsequent to the date hereof, the Company shall notify the Investor as to its reasonable expectations as to the dollar amount it intends to raise during such calendar quarter, if any, through the issuance of Draw Down Notices.  Such notification shall constitute only the Company’s good faith estimate with respect to such calendar quarter and shall in no way obligate the Company to raise such amount during such calendar quarter or otherwise limit or restrict its right to deliver Draw Down Notices during such calendar quarter in any amount permitted under this Agreement or to refrain from delivering any Draw Down Notices during such quarter.  The failure by the Company to comply with this provision can be cured by
the Company’s notifying the Investor at any time as to its reasonable expectations with respect to the current calendar quarter.

17

ARTICLE VII

CONDITIONS TO THE OBLIGATION OF THE INVESTOR TO ACCEPT A DRAW DOWN

          The obligation of the Investor hereunder to accept a Draw Down Notice and to acquire and pay for the Shares in accordance therewith is subject to the satisfaction or waiver, at each Condition Satisfaction Date, of each of the conditions set forth below.  Other than those conditions set forth in Section 7.13 which are for the Company’s sole benefit and may be waived by the Company at any time in its sole discretion, the conditions are for the Investor’s sole benefit and may be waived by the Investor at any time in its sole discretion.  As used in this Agreement, the term “Condition Satisfaction Date” shall mean, with respect to each Draw Down, the date on which the applicable Draw Down Notice is delivered to the Investor and each Settlement Date in respect of the applicable Draw Down Pricing Period.

          Section 7.01.     Accuracy of the Company’s Representations and Warranties.  Each of the representations and warranties of the Company shall be true and correct in all material respects as of the date when made as though made at that time except for representations and warranties that are expressly made as of a particular date.

          Section 7.02.     Performance by the Company.  The Company shall have, in all material respects, performed, satisfied and complied with all covenants, agreements and conditions required by this Agreement, the Registration Rights Agreement and the Warrant to be performed, satisfied or complied with by the Company.

          Section 7.03.     Compliance with Law.  The Company shall have complied in all material respects with all applicable federal, state and local governmental laws, rules, regulations and ordinances in connection with the execution, delivery and performance of this Agreement and the consummation of the transactions contemplated hereby.

          Section 7.04.     Effective Registration Statement.  Upon the terms and subject to the conditions set forth in the Registration Rights Agreement, the Registration Statement shall have previously become effective and shall remain effective and (i) neither the Company nor the Investor shall have received notice that the Commission has issued or intends to issue a stop order with respect to the Registration Statement or that the Commission otherwise has suspended or withdrawn the effectiveness of the Registration Statement, either temporarily or permanently, or intends or has threatened to do so (unless the Commission’s concerns have been addressed and the Investor is reasonably satisfied that the Commission no longer is considering or intends to take such action), and (ii) no other suspension of the use or withdrawal of the effectiveness of the
Registration Statement or the Prospectus shall exist.

          Section 7.05.     No Knowledge.  The Company shall have no Knowledge of any event that could reasonably be expected to have the effect of causing the Registration Statement with respect to the resale of the Registrable Securities by the Investor to be suspended or otherwise ineffective (which event is more likely than not to occur within fifteen Trading Days following the Trading Day on which a Draw Down Notice is delivered).

          Section 7.06.     No Suspension.  Trading in the Company’s Common Stock shall not have been suspended by the Commission, the Principal Market or the NASD and trading in securities generally as reported on the Principal Market shall not have been suspended or limited.

18

          Section 7.07.     No Injunction.  No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed by any court or governmental authority of competent jurisdiction which prohibits the consummation of any of the transactions contemplated by this Agreement.

          Section 7.08.     No Proceedings or Litigation.  No action, suit or proceeding before any arbitrator or any governmental authority shall have been commenced, and no investigation by any governmental authority shall have been threatened, against the Company or any subsidiary, or any of the officers, directors or affiliates of the Company or any subsidiary seeking to enjoin, prevent or change the transactions contemplated by this Agreement.

          Section 7.09.     Section 16 Limitation.  On each Settlement Date, the number of Shares then to be purchased by the Investor shall not exceed the number of such shares that, when aggregated with all other Registrable Securities then owned by the Investor beneficially or deemed beneficially owned by the Investor, would result in the Investor owning more than 9.9% of all of such Common Stock as would be outstanding on such Settlement Date, as determined in accordance with Section 16 of the Exchange Act.  For purposes of this Section 7.09, in the event that the amount of Common Stock outstanding as determined in accordance with Section 16 of the Exchange Act and the regulations promulgated thereunder is greater on a Settlement Date than on the date upon which the Draw Down Notice associated with such Settlement Date is given, the amount of Common
Stock outstanding on such Settlement Date shall govern for purposes of determining whether the Investor, when aggregating all purchases of Common Stock made pursuant to this Agreement and, if any, Warrant Shares and Blackout Shares, would own more than 9.9% of the Common Stock following such Settlement Date.

          Section 7.10.     Sufficient Shares Registered for Resale.  The Company shall have sufficient Shares, calculated using the closing trade price of the Common Stock as of the Trading Day immediately preceding such Draw Down Notice, registered under the Registration Statement to issue and sell such Shares in accordance with such Draw Down Notice.

          Section 7.11.     Warrant.  The Warrant shall have been duly executed, delivered and issued to the Investor, and the Company shall not be in default in any material respect under any of the provisions thereof, provided that any refusal by or failure of the Company to issue and deliver Warrant Shares in respect of any exercise (in whole or in part) thereof shall be deemed to be material for the purposes of this Section 7.11.

          Section 7.12.     Opinion of Counsel.  The Investor shall have received an opinion of counsel to the Company, dated as of the Effective Date, in the form reasonably agreed to by the Investor and its counsel prior to the date hereof.

          Section 7.13.     Accuracy of Investor’s Representation and Warranties.  The representations and warranties of the Investor shall be true and correct in all material respects as of the date when made as though made at that time except for representations and warranties that are made as of a particular date.

ARTICLE VIII

TERMINATION

          Section 8.01.     Term.  Unless otherwise terminated in accordance with Section 8.02 below, this Agreement shall terminate upon the expiration of the Commitment Period.

19

          Section 8.02.     Other Termination.

          (a)     The Investor may terminate this Agreement upon (x) one (1) day’s notice if the Company enters into any Prohibited Transaction as set forth in Section 6.08 without the Investor’s prior written consent, or (y) one (1) day’s notice within ten (10) Trading Days after the Investor obtains actual knowledge that an event resulting in a Material Adverse Effect has occurred; provided, however, that such Material Adverse Effect is not the result of (i) the formation or dissolution of any partnership or other agreement entered into by the Company, or (ii) the results of any clinical trial, in either case, in the ordinary course of the Company’s research and development activities; provided further, that the Investor shall be deemed to possess such actual knowledge within five (5) Trading Days after such event has been publicly
disclosed by the Company in accordance with its reporting requirements under the Exchange Act.

          (b)     The Investor may terminate this Agreement upon one (1) day’s notice to the Company at any time in the event that the Registration Statement is not declared effective in accordance with the Registration Rights Agreement.

          (c)     The Company may terminate this Agreement upon one (1) day’s notice; provided, however, that the Company shall not terminate this Agreement pursuant to this Section 8.02(c) during any Draw Down Pricing Period; provided further; that, in the event of any termination of this Agreement by the Company hereunder, so long as the Investor owns Shares purchased hereunder and/or Warrant Shares, unless all of such shares of Common Stock may be resold by the Investor without registration and without any time, volume or manner limitations pursuant to Rule 144(k) (or any similar provision then in effect) under the Securities Act, the Company shall not suspend or withdraw the Registration Statement or otherwise cause the Registration Statement to become ineffective, or voluntarily delist the Common Stock from, the Principal Market without
listing the Common Stock on another Principal Market.

          (d)     Each of the parties hereto may terminate this Agreement upon one (1) day’s notice if the other party has breached a material representation, warranty or covenant to this Agreement and such breach is not remedied within ten (10) Trading Days after notice of such breach is delivered to the breaching party.

          (e)     The obligation of the Investor to purchase shares of Common Stock shall terminate permanently in the event that the Commission shall issue any stop order concerning, or suspend the effectiveness of, the Registration Statement for an aggregate of thirty (30) calendar days during the Commitment Period.

          Section 8.03.     Effect of Termination.  In the event of termination by the Company or the Investor, written notice thereof shall forthwith be given to the other party and the transactions contemplated by this Agreement shall be terminated without further action by either party.  If this Agreement is terminated as provided in Section 8.01 or 8.02 herein, this Agreement shall become void and of no further force and effect, except as provided in Section 10.13.  Nothing in this Section 8.03 shall be deemed to release the Company or the Investor from any liability for any breach under this Agreement occurring prior to such termination, or to impair the rights of the Company and the Investor to compel specific performance by the other party of its obligations under this Agreement arising prior to such termination.

20

ARTICLE IX

INDEMNIFICATION

          Section 9.01.     Indemnification.

          (a)     Except as otherwise provided in this Article IX, unless disputed as set forth in Section 9.02, the Company agrees to indemnify, defend and hold harmless the Investor and its affiliates and their respective officers, directors, agents, employees, subsidiaries, partners, members and controlling persons (each, an “Investor Indemnified Party”), to the fullest extent permitted by law from and against any and all Damages directly resulting from or directly arising out of any breach of any representation or warranty, covenant or agreement by the Company in this Agreement, the Registration Rights Agreement or the Warrant; provided, however, that the Company shall not be liable under this Article IX to an Investor Indemnified Party to the extent that such Damages resulted or arose from the breach by an Investor Indemnified Party of any
representation, warranty, covenant or agreement of an Investor Indemnified Party contained in this Agreement, the Registration Rights Agreement or the Warrant or the gross negligence, recklessness, willful misconduct or bad faith of an Investor Indemnified Party.  The parties intend that any Damages subject to indemnification pursuant to this Article IX will be net of insurance proceeds (which the Investor Indemnified Party agrees to use commercially reasonable efforts to recover).  Accordingly, the amount which the Company is required to pay to any Investor Indemnified Party hereunder (a “Company Indemnity Payment”) will be reduced by any insurance proceeds actually recovered by or on behalf of any Investor Indemnified Party in reduction of the related Damages. In addition, if an Investor Indemnified Party receives a Company Indemnity Payment required by this Article IX in respect of any Damages and subsequently receives any such insurance proceeds, then the
Investor Indemnified Party will pay to the Company an amount equal to the Company Indemnity Payment received less the amount of the Company Indemnity Payment that would have been due if the insurance proceeds had been received, realized or recovered before the Company Indemnity Payment was made.

          (b)     Except as otherwise provided in this Article IX, unless disputed as set forth in Section 9.02, the Investor agrees to indemnify, defend and hold harmless the Company and its affiliates and their respective officers, directors, agents, employees, subsidiaries, partners, members and controlling persons (each, a “Company Indemnified Party”), to the fullest extent permitted by law from and against any and all Damages directly resulting from or directly arising out of any breach of any representation or warranty, covenant or agreement by the Investor in this Agreement, the Registration Right Agreement or the Warrant; provided, however, that the Investor shall not be liable under this Article IX to a Company Indemnified Party to the extent that such Damages resulted or arose from the breach by a Company Indemnified Party of any
representation, warranty, covenant or agreement of a Company Indemnified Party contained in this Agreement, the Registration Right Agreement or the Warrant or gross negligence, recklessness, willful misconduct or bad faith of a Company Indemnified Party.  The parties intend that any Damages subject to indemnification pursuant to this Article IX will be net of insurance proceeds (which the Company agrees to use commercially reasonable efforts to recover).  Accordingly, the amount which the Investor is required to pay to any Company Indemnified Party hereunder (an “Investor Indemnity Payment”) will be reduced by any insurance proceeds theretofore actually recovered by or on behalf of any Company Indemnified Party in reduction of the related Damages.  In addition, if a Company Indemnified Party receives an Investor Indemnity Payment required by this Article IX in respect of any Damages and subsequently receives any such insurance proceeds, then the Company
Indemnified Party will pay to the Investor an amount equal to the Investor Indemnity Payment received less the amount of the Investor Indemnity Payment that would have been due if the insurance proceeds had been received, realized or recovered before the Investor Indemnity Payment was made.

21

          Section 9.02.     Notification of Claims for Indemnification.  Each party entitled to indemnification under this Article IX (an “Indemnified Party”) shall, promptly after the receipt of notice of the commencement of any claim against such Indemnified Party in respect of which indemnity may be sought from the party obligated to indemnify such Indemnified Party under this Article IX (the “Indemnifying Party”), notify the Indemnifying Party in writing of the commencement thereof.  Any such notice shall describe the claim in reasonable detail.  The failure of any Indemnified Party to so notify the Indemnifying Party of any such action shall not relieve the Indemnifying Party from any liability which it may have to such Indemnified Party (a) other than pursuant to this Article IX or (b) under this Article IX
unless, and only to the extent that, such failure results in the Indemnifying Party’s forfeiture of substantive rights or defenses or the Indemnifying Party is prejudiced by such delay.  The procedures listed below shall govern the procedures for the handling of indemnification claims.

          (a)     Any claim for indemnification for Damages that do not result from a Third Party Claim as defined in the following paragraph, shall be asserted by written notice given by the Indemnified Party to the Indemnifying Party.  Such Indemnifying Party shall have a period of thirty (30) days after the receipt of such notice within which to respond thereto.  If such Indemnifying Party does not respond within such thirty (30) day period, such Indemnifying Party shall be deemed to have refused to accept responsibility to make payment as set forth in Section 9.01.  If such Indemnifying Party does not respond within such thirty (30) day period or rejects such claim in whole or in part, the Indemnified Party shall be free to pursue such remedies as specified in this Agreement, including the dispute resolution provisions set forth in Section 9.03 below.

          (b)     If an Indemnified Party shall receive notice or otherwise learn of the assertion by a person or entity not a party to this Agreement of any threatened legal action or claim (collectively a “Third Party Claim”), with respect to which an Indemnifying Party may be obligated to provide indemnification, the Indemnified Party shall give such Indemnifying Party written notice thereof within twenty (20) days after becoming aware of such Third Party Claim.

          (c)     An Indemnifying Party may elect to defend (and, unless the Indemnifying Party has specified any reservations or exceptions, to seek to settle or compromise) at such Indemnifying Party’s own expense and by such Indemnifying Party’s own counsel, any Third Party Claim.  Within thirty (30) days after the receipt of notice from an Indemnified Party (or sooner if the nature of such Third Party Claim so requires), the Indemnifying Party shall notify the Indemnified Party whether the Indemnifying Party will assume responsibility for defending such Third Party Claim, which election shall specify any reservations or exceptions.  If such Indemnifying Party does not respond within such thirty (30) day period or rejects such claim in whole or in part, the Indemnified Party shall be free to pursue such remedies as specified in this Agreement, including the dispute
resolution provisions set forth in Section 9.03 below.  In case any such Third Party Claim shall be brought against any Indemnified Party, and it shall notify the Indemnifying Party of the commencement thereof, the Indemnifying Party shall be entitled to assume the defense thereof at its own expense, with counsel satisfactory to such Indemnified Party in its reasonable judgment; provided, however, that any Indemnified Party may, at its own expense, retain separate counsel to participate in such defense at its own expense.  Notwithstanding the foregoing, in any Third Party Claim in which both the Indemnifying Party, on the one hand, and an Indemnified Party, on the other hand, are, or are reasonably likely to become, a party, such Indemnified Party shall have the right to employ separate counsel and to 

22

control its own defense of such claim if, in the reasonable opinion of counsel to such Indemnified Party, either (x) one or more significant defenses are available to the Indemnified Party that are not available to the Indemnifying Party or (y) a conflict or potential conflict exists between the Indemnifying Party, on the one hand, and such Indemnified Party, on the other hand, that would make such separate representation advisable; provided, however, that in such circumstances the Indemnifying Party (i) shall not be liable for the fees and expenses of more than one counsel to all Indemnified Parties and (ii) shall reimburse the Indemnified Parties for such reasonable fees and expenses of such counsel incurred in any such Third Party Claim, as such expenses are incurred, provided that the Indemnified Parties agree to repay such amounts if it is ultimately determined that the Indemnifying Party was not obligated to provide
indemnification under this Article X.  The Indemnifying Party agrees that it will not, without the prior written consent of the Indemnified Party, settle, compromise or consent to the entry of any judgment in any pending or threatened claim relating to the matters contemplated hereby (if any Indemnified Party is a party thereto or has been actually threatened to be made a party thereto) unless such settlement, compromise or consent includes an unconditional release of such Indemnified Party from all liability arising or that may arise out of such claim.  The Indemnifying Party shall not be liable for any settlement of any claim effected against an Indemnified Party without the Indemnifying Party’s written consent, which consent shall not be unreasonably withheld, conditioned or delayed.  The rights accorded to an Indemnified Party hereunder shall be in addition to any rights that any Indemnified Party may have at common law, by separate agreement or otherwise (subject,
however, to the provisions of Section 9.03 below); provided, however, that notwithstanding the foregoing or anything to the contrary contained in this Agreement, nothing in this Article X (other than Section 9.03) shall restrict or limit any rights that any Indemnified Party may have to seek equitable relief.

          Section 9.03.     Dispute Resolution. Any dispute under this Agreement, the Registration Rights Agreement or the Warrant shall be submitted to arbitration (including, without limitation, pursuant to this Article IX) and shall be finally and conclusively determined by the decision of a board of arbitration consisting of three (3) members (the “Board of Arbitration”) selected as hereinafter provided.  Each of the Indemnified Party and the Indemnifying Party shall select one (1) member and the third member shall be selected by mutual agreement of the other members, or if the other members fail to reach agreement on a third member within twenty (20) days after their selection, such third member shall thereafter be selected by the American Arbitration Association upon application made to it for such purpose by the Indemnified Party.  The Board
of Arbitration shall meet on consecutive business days in New York, New York or such other place as a majority of the members of the Board of Arbitration determines more appropriate, and shall reach and render a decision in writing (concurred in by a majority of the members of the Board of Arbitration) with respect to the amount, if any, which the Indemnifying Party is required to pay to the Indemnified Party in respect of a claim filed by the Indemnified Party.  In connection with rendering its decisions, the Board of Arbitration shall adopt and follow such rules and procedures as a majority of the members of the Board of Arbitration deems necessary or appropriate.  To the extent practical, decisions of the Board of Arbitration shall be rendered no more than thirty (30) calendar days following commencement of proceedings with respect thereto.  The Board of Arbitration shall cause its written decision to be delivered to the Indemnified Party and the Indemnifying Party.  Any
decision made by the Board of Arbitration (either prior to or after the expiration of such thirty (30) calendar day period) shall be final, binding and conclusive on the Indemnified Party and the Indemnifying Party and entitled to be enforced to the fullest extent permitted by law and entered in any court of competent jurisdiction.  Each party to any arbitration shall bear its own expense in relation thereto, including but not limited to such party’s attorneys’ fees, if any, and the expenses and fees of the Board of Arbitration shall be paid initially one-half by each of the Indemnifying Party and the Indemnified Party, but then apportioned between the Indemnifying Party and the Indemnified Party in the same proportion as the portion of the related claim determined by the Board of Arbitration to be payable to the Indemnified Party bears to the portion of such claim determined not to be so payable.

23

ARTICLE X

MISCELLANEOUS

          Section 10.01.     Fees and Expenses.  Each of the Company and the Investor agrees to pay its own expenses incident to the performance of its obligations hereunder, except that the Company shall be solely responsible for (i)  all reasonable attorneys fees and expenses incurred by the Investor in connection with the preparation, negotiation, execution and delivery of this Agreement, the Registration Rights Agreement and the Warrant, up to an aggregate maximum amount of $60,000, and (ii) all reasonable fees and expenses incurred by the Investor in connection with any amendments, modifications or waivers of this Agreement, including, without limitation, all reasonable attorneys fees and expenses up to an aggregate maximum amount of $7,500, and (iii) all reasonable fees and expenses incurred in connection with the Investor’s enforcement of this Agreement,
including, without limitation, all reasonable attorneys fees and expenses, and (iv) due diligence expenses incurred by the Investor during the term of this Agreement equal to $12,500 per calendar quarter, provided that such $12,500 shall not be payable in respect of any calendar quarter following the calendar quarter during which the Company shall have issued and sold Common Stock hereunder during the term of this Agreement in aggregate Draw Down Amounts equal to or exceeding $5 million, and (v) all stamp or other similar taxes and duties, if any, levied in connection with issuance of the Shares pursuant hereto; provided, however, that in each of the above instances the Investor shall provide customary supporting invoices or similar documentation in reasonable detail describing such expenses.  The Company shall also pay the reasonable fees and expenses of Investor’s counsel incurred in connection with such counsel’s review of the Registration Statement in
accordance with the terms of the Registration Rights Agreement, including the limitation contained therein.

          Section 10.02.     Reporting Entity for the Common Stock.  The reporting entity relied upon for the determination of the trading price or trading volume of the Common Stock on any given Trading Day for the purposes of this Agreement shall be Bloomberg, L.P. or any successor thereto.  The written mutual consent of the Investor and the Company shall be required to employ any other reporting entity.

          Section 10.03.     Brokerage. Each of the parties hereto represents that it has had no dealings in connection with this transaction with any finder or broker who will demand payment of any fee or commission from the other party.  The Company on the one hand, and the Investor, on the other hand, agree to indemnify the other against and hold the other harmless from any and all liabilities to any Persons claiming brokerage commissions or finder’s fees on account of services purported to have been rendered on behalf of the indemnifying party in connection with this Agreement or the transactions contemplated hereby.

          Section 10.04.     Notices.  All notices, demands, requests, consents, approvals, and other communications required or permitted hereunder shall be in writing and, unless otherwise specified herein, shall be (i) personally served, (ii) deposited in the mail, registered or certified, return receipt requested, postage prepaid, (iii) delivered by reputable air courier service with charges prepaid, or (iv) transmitted by hand delivery, telegram, or facsimile, addressed as set forth below or to such other address as such party shall have specified most recently by written notice given in accordance herewith.  Any notice or other communication required or permitted to 

24

be given hereunder shall be deemed effective (a) upon hand delivery or delivery by facsimile, with accurate confirmation generated by the transmitting facsimile machine, at the address or number designated below (if delivered on a business day during normal business hours where such notice is to be received), or the first business day following such delivery (if delivered other than on a business day during normal business hours where such notice is to be received) or (b) on the second business day following the date of mailing by express courier service, fully prepaid, addressed to such address, or upon actual receipt of such mailing, whichever shall first occur.  The addresses for such communications shall be:

	
  
 
  	
  
If to the   Company:
  
	
  
 
  	
  
 
  
	
  
 
  	
  
Emisphere   Technologies, Inc.
  
	
  
 
  	
  
765 Old Saw   Mill River Road, 
  
	
  
 
  	
  
Tarrytown,   NY 10591
  
	
  
 
  	
  
Telephone:
  
	
  
 
  	
  
Facsimile:
  
	
  
 
  	
  
Attention:  Chief   Financial Officer
  
	
  
 
  	
  
 
  
	
  
with a copy   (which shall not constitute notice) to:
  
	
   
  	
  
 
  
	
  
 
  	
  
Proskauer   Rose LLP
  
	
  
 
  	
  
1585   Broadway
  
	
  
 
  	
  
New York,   New York 10036-8299
  
	
  
 
  	
  
Telephone:   212-969-3000 
  
	
  
 
  	
  
Fax:   212-969-2900 
  
	
  
 
  	
  
Attention:   Robert A. Cantone, Esq.
  
	
  
 
  	
  
 
  
	
  
if to the   Investor:
  
	
  
 
  	
  
 
  
	
  
 
  	
  
Kingsbridge   Capital Limited/ c/o Kingsbridge Corporate Services Limited
  
	
   
  	
  
Main Street
  
	
  
 
  	
  
Kilcullen,   County Kildare
  
	
  
 
  	
  
Republic of   Ireland
  
	
  
 
  	
  
Telephone:  011-353-45-481-811
  
	
  
 
  	
  
Facsimile:  011-353-45-482-003
  
	
  
 
  	
  
Attention:  Adam Gurney, Managing Director
  
	
  
 
  	
  
 
  
	
  
with a copy   (which shall not constitute notice) to:
  
	
  
 
  	
  
 
  
	
  
 
  	
  
Clifford   Chance US LLP
  
	
  
 
  	
  
31 West 52nd   Street
  
	
   
  	
  
New York,   NY  10019
  
	
  
 
  	
  
Telephone:   (212) 878-8000
  
	
  
 
  	
  
Facsimile:   (212) 878-8375
  
	
  
 
  	
  
Attention:   Keith M. Andruschak, Esq.
  

Either party hereto may from time to time change its address or facsimile number for notices under this Section by giving at least ten (10) days’ prior written notice of such changed address or facsimile number to the other party hereto.

          Section 10.05.     Assignment.  Neither this Agreement nor any rights of the Investor or the Company hereunder may be assigned by either party to any other Person.

25

          Section 10.06.     Amendment; No Waiver.  No party shall be liable or bound to any other party in any manner by any warranties, representations or covenants except as specifically set forth in this Agreement, the Warrant and the Registration Rights Agreement.  Except as expressly provided in this Agreement, neither this Agreement nor any term hereof may be amended, waived, discharged or terminated other than by a written instrument signed by both parties hereto.  The failure of the either party to insist on strict compliance with this Agreement, or to exercise any right or remedy under this Agreement, shall not constitute a waiver of any rights provided under this Agreement, nor estop the parties from thereafter demanding full and complete compliance nor prevent the parties from exercising such a right or remedy in the future.

          Section 10.07.     Entire Agreement.  This Agreement, the Registration Rights Agreement and the Warrant set forth the entire agreement and understanding of the parties relating to the subject matter hereof and supersedes all prior and contemporaneous agreements, negotiations and understandings between the parties, both oral and written, relating to the subject matter hereof.

          Section 10.08.     Severability.  In the event that any provision of this Agreement becomes or is declared by a court of competent jurisdiction to be illegal, unenforceable or void, this Agreement shall continue in full force and effect without said provision; provided that, such severability shall be ineffective if it materially changes the economic benefit of this Agreement to any party.

          Section 10.09.     Title and Subtitles.  The titles and subtitles used in this Agreement are used for the convenience of reference and are not to be considered in construing or interpreting this Agreement.

          Section 10.10.     Counterparts.  This Agreement may be executed in multiple counterparts, each of which may be executed by less than all of the parties and shall be deemed to be an original instrument which shall be enforceable against the parties actually executing such counterparts and all of which together shall constitute one and the same instrument.

          Section 10.11.     Choice of Law.  This Agreement shall be construed under the laws of the State of New York.

          Section 10.12.     Specific Enforcement, Consent to Jurisdiction.

          (a)     The Company and the Investor acknowledge and agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached.  It is accordingly agreed that the parties shall be entitled to an injunction or injunctions to prevent or cure breaches of the provisions of this Agreement and to enforce specifically the terms and provisions hereof or thereof, this being in addition to any other remedy to which any of them may be entitled by law or equity.

          (b)     Subject to Section 9.03, each of the Company and the Investor (i) hereby irrevocably submits to the jurisdiction of the United States District Court and other courts of the United States sitting in the State of New York for the purposes of any suit, action or proceeding arising out of or relating to this Agreement and (ii) hereby waives, and agrees not to assert in any such suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of such court, that the suit, action or proceeding is brought in an inconvenient forum or that the venue of the suit, action or proceeding is improper.  Each of the Company and the Investor consents to process being served in any such suit, action or proceeding by mailing a copy thereof to such party at the address in effect for notices to it under this Agreement and agrees that such
service shall constitute good and sufficient service of process and notice thereof.  Nothing in this Section shall affect or limit any right to serve process in any other manner permitted by law.

26

          Section 10.13.     Survival.  The representations and warranties of the Company and the Investor contained in Articles IV and V and the covenants contained in Article V and Article VI shall survive the execution and delivery hereof and the Closing until the termination of this Agreement, and the agreements and covenants set forth in Article VIII and Article IX of this Agreement shall survive the execution and delivery hereof and the Closing hereunder.

          Section 10.14.     Publicity  Except as otherwise required by applicable law or regulation, or Nasdaq rule or judicial process, prior to the Closing, neither the Company nor the Investor shall issue any press release or otherwise make any public statement or announcement with respect to this Agreement or the transactions contemplated hereby or the existence of this Agreement.  In the event the Company is required by law, regulation, Nasdaq rule or judicial process, based upon reasonable advice of the Company’s counsel, to issue a press release or otherwise make a public statement or announcement with respect to this Agreement prior to the Closing, the Company shall consult with the Investor on the form and substance of such press release, statement or announcement.  Promptly after the Closing, each party may issue a press release or otherwise make a
public statement or announcement with respect to this Agreement or the transactions contemplated hereby or the existence of this Agreement; provided that, prior to issuing any such press release, making any such public statement or announcement, the party wishing to make such release, statement or announcement consults and cooperates in good faith with the other party in order to formulate such press release, public statement or announcement in form and substance reasonably acceptable to both parties.

          Section 10.15.     Further Assurances.  From and after the date of this Agreement, upon the request of the Investor or the Company, each of the Company and the Investor shall execute and deliver such instruments, documents and other writings as may be reasonably necessary or desirable to confirm and carry out and to effectuate fully the intent and purposes of this Agreement.

[Remainder of this page intentionally left blank]

27

                    IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by their respective authorized officer as of the date first written.

	
  
 
  	
  
KINGSBRIDGE CAPITAL   LIMITED
  
	
  
 
  	
  
 
  	
  
 
  
	
  
 
  	
  
 
  	
  
 
  
	
   
  	
  
By:
  	
  
/s/   Valentine O’Donoghue
  
	
  
 
  	
  
 
  	
  

  
	
  
 
  	
  
 
  	
  
Valentine   O’Donoghue
  
	
  
 
  	
  
 
  	
  
Director
  
	
  
 
  	
  
 
  
	
  
 
  	
  
 
  
	
  
 
  	
  
EMISPHERE TECHNOLOGIES, INC.
  
	
  
 
  	
  
 
  	
  
 
  
	
   
  	
  
 
  	
  
 
  
	
  
 
  	
  
By:
  	
  
/s/Elliot M.   Maza
  
	
  
 
  	
  
 
  	
  

  
	
  
 
  	
  
 
  	
  
Elliot M.   Maza
  
	
  
 
  	
  
 
  	
  
Chief   Financial Officer
  

28

Exhibit A

Form of Registration Rights Agreement

Exhibit B

Form of Warrant

Exhibit C

Officer’s Certificate

          I, [NAME OF OFFICER], do hereby certify to Kingsbridge Capital Limited (the “Investor”), with respect to the common stock of Emisphere Technologies, Inc. (the “Company”) issuable in connection with the Draw Down Notice, dated _____________ (the “Notice”) attached hereto and delivered pursuant to Article III of the Common Stock Purchase Agreement, dated December 27, 2004 (the “Agreement”), by and between the Company and the Investor, as follows:

          1.          I am the duly elected [OFFICER] of the Company.

          2.          The representations and warranties of the Company set forth in Article IV of the Agreement are true and correct in all material respects as though made on and as of the date hereof (except for such representations and warranties that are made as of a particular date).

          3.          The Company has performed in all material respects all covenants and agreements to be performed by the Company on or prior to the date hereof related to the Notice and has satisfied each of the conditions to the obligation of the Investor set forth in Article VII of the Agreement.

          The undersigned has executed this Certificate this ____ day of ________, 200[_].

	
  
 
  	
  

  
	
   
  	
  Name:
  
	
   
  	
  Title:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00077-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00077-of-00352.parquet"}]]